| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH4 MYO1D CENPF MYH7B SPTA1 KTN1 CEP290 EPB41L5 RDX MYO1B SHANK3 CCDC88A DST BRCA1 BAIAP2L1 BRCA2 EGFR SYNE2 CEP135 COBL CDK5RAP2 CEP295 FHDC1 CAMSAP1 UTRN | 2.98e-06 | 1099 | 173 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH4 MYO1D MYH7B SPTA1 RDX MYO1B SHANK3 CCDC88A DST BAIAP2L1 EGFR SYNE2 COBL FHDC1 UTRN | 4.46e-06 | 479 | 173 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.60e-05 | 37 | 173 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.83e-05 | 38 | 173 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.83e-05 | 38 | 173 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.34e-05 | 230 | 173 | 10 | GO:0005516 | |
| GeneOntologyMolecularFunction | DNA clamp unloader activity | 7.46e-05 | 2 | 173 | 2 | GO:0061860 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.63e-05 | 118 | 173 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH4 BRIP1 MYO1D ATAD5 MYH7B SMC1A MYO1B RFC1 DHX8 RAD50 NLRP10 RECQL5 DNAH8 DNAH11 | 3.04e-04 | 614 | 173 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | zinc ion binding | TRAF5 ZNF407 ERVK-7 ERVK-21 ERVK-9 ERI2 ESCO1 SHANK3 GATAD2B ZBBX ZNF675 BRCA1 KDM7A EEA1 ZNF91 TRIM13 ERVK-24 UTRN | 7.48e-04 | 891 | 173 | 18 | GO:0008270 |
| GeneOntologyBiologicalProcess | centriole replication | 2.94e-06 | 47 | 177 | 6 | GO:0007099 | |
| GeneOntologyBiologicalProcess | DNA replication | ATAD5 ERVK-7 RFC1 YY1 ESCO1 RAD50 FAM111A BRCA1 BRCA2 EGFR RECQL5 PDS5A ILKAP | 3.15e-06 | 312 | 177 | 13 | GO:0006260 |
| GeneOntologyBiologicalProcess | organelle assembly | TEKT3 CEP85 CENPF SMC1A SDCCAG8 CEP290 RDX RB1CC1 SHANK3 CCDC39 CEP164 FSIP2 CCDC88A BRCA1 SYNE2 CEP135 SASS6 CDK5RAP2 CEP295 FHDC1 CFAP70 CCDC65 DNAH8 VPS13B KNL1 PCNT | 4.80e-06 | 1138 | 177 | 26 | GO:0070925 |
| GeneOntologyBiologicalProcess | centriole assembly | 6.03e-06 | 53 | 177 | 6 | GO:0098534 | |
| GeneOntologyBiologicalProcess | centrosome duplication | 6.20e-06 | 81 | 177 | 7 | GO:0051298 | |
| GeneOntologyBiologicalProcess | microtubule-based process | TEKT3 CACNA1E CEP85 SMC1A SDCCAG8 KTN1 CEP290 CCDC39 FSIP2 CCDC88A DST BRCA1 BRCA2 SYNE2 CEP135 SASS6 CDK5RAP2 CEP295 CFAP70 CAMSAP1 CCDC65 DNAH8 PCNT DNAH11 | 1.30e-05 | 1058 | 177 | 24 | GO:0007017 |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 1.34e-05 | 36 | 177 | 5 | GO:0035459 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CEP85 SMC1A SDCCAG8 CEP290 CCDC39 FSIP2 CCDC88A DST BRCA1 BRCA2 SYNE2 CEP135 SASS6 CDK5RAP2 CEP295 CAMSAP1 CCDC65 DNAH8 PCNT | 1.45e-05 | 720 | 177 | 19 | GO:0000226 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 2.39e-05 | 178 | 177 | 9 | GO:0006261 | |
| GeneOntologyBiologicalProcess | cilium assembly | TEKT3 SDCCAG8 CEP290 CCDC39 CEP164 FSIP2 CCDC88A SYNE2 CEP135 FHDC1 CFAP70 CCDC65 DNAH8 PCNT | 3.09e-05 | 444 | 177 | 14 | GO:0060271 |
| GeneOntologyBiologicalProcess | cilium organization | TEKT3 SDCCAG8 CEP290 CCDC39 CEP164 FSIP2 CCDC88A SYNE2 CEP135 FHDC1 CFAP70 CCDC65 DNAH8 PCNT | 6.55e-05 | 476 | 177 | 14 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of centriole replication | 6.76e-05 | 26 | 177 | 4 | GO:0046599 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | TEKT3 SDCCAG8 CEP290 RDX CCDC39 CEP164 FSIP2 CCDC88A SYNE2 CEP135 COBL FHDC1 CFAP70 CCDC65 DNAH8 NCK2 PCNT | 6.80e-05 | 670 | 177 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | DNA clamp unloading | 7.32e-05 | 2 | 177 | 2 | GO:0090618 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 8.79e-05 | 164 | 177 | 8 | GO:0007098 | |
| GeneOntologyBiologicalProcess | cell projection assembly | TEKT3 SDCCAG8 CEP290 RDX CCDC39 CEP164 FSIP2 CCDC88A SYNE2 CEP135 COBL FHDC1 CFAP70 CCDC65 DNAH8 NCK2 PCNT | 8.90e-05 | 685 | 177 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 1.61e-04 | 179 | 177 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | homologous chromosome orientation in meiotic metaphase I | 2.18e-04 | 3 | 177 | 2 | GO:0031619 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH4 MYO1D MYH7B SPTA1 EPB41L5 RDX MYO1B PFDN1 TF SHANK3 ARHGAP6 CCDC88A BAIAP2L1 SYNE2 COBL AKAP11 MYH16 FHDC1 NCK2 | 3.27e-04 | 912 | 177 | 19 | GO:0030029 |
| GeneOntologyCellularComponent | centriole | CEP85 SDCCAG8 CEP290 CEP164 CEP170 CCDC88A CEP135 SASS6 CEP295 PCNT | 1.85e-06 | 172 | 174 | 10 | GO:0005814 |
| GeneOntologyCellularComponent | cilium | TEKT3 TBX3 RIBC2 CENPF SDCCAG8 CEP290 RAPGEF4 CCDC178 SHANK3 CCDC39 CEP164 PIK3R4 CEP170 FSIP2 CCDC88A FHDC1 CFAP70 CCDC65 DNAH8 PMFBP1 PCNT DNAH11 | 5.83e-06 | 898 | 174 | 22 | GO:0005929 |
| GeneOntologyCellularComponent | microtubule organizing center | TRAF5 CEP85 CENPF SDCCAG8 CEP290 CCDC178 CCDC141 BIRC6 CEP164 CEP170 CCDC88A BRCA1 BRCA2 CEP135 SASS6 CDK5RAP2 AKAP11 CEP295 CFAP70 CAMSAP1 CCDC65 PCNT | 8.39e-06 | 919 | 174 | 22 | GO:0005815 |
| GeneOntologyCellularComponent | myosin complex | 9.54e-06 | 59 | 174 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | lateral element | 1.63e-05 | 19 | 174 | 4 | GO:0000800 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.50e-05 | 42 | 174 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | axoneme | 6.14e-05 | 207 | 174 | 9 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 6.38e-05 | 208 | 174 | 9 | GO:0097014 | |
| GeneOntologyCellularComponent | centrosome | TRAF5 CEP85 CENPF SDCCAG8 CEP290 CCDC141 BIRC6 CEP164 CEP170 CCDC88A BRCA1 BRCA2 CEP135 SASS6 CDK5RAP2 AKAP11 CEP295 PCNT | 7.93e-05 | 770 | 174 | 18 | GO:0005813 |
| GeneOntologyCellularComponent | Elg1 RFC-like complex | 2.06e-04 | 3 | 174 | 2 | GO:0031391 | |
| GeneOntologyCellularComponent | ciliary basal body | 2.35e-04 | 195 | 174 | 8 | GO:0036064 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | TEKT3 RIBC2 CENPF CCDC39 PIK3R4 DST CFAP70 CCDC65 DNAH8 DNAH11 | 3.37e-04 | 317 | 174 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH4 MYO1D MYH7B SPTA1 ITSN1 RDX MYO1B ARHGAP6 DST BAIAP2L1 COBL MYH16 FHDC1 | 3.43e-04 | 576 | 174 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | BRCA1-B complex | 4.09e-04 | 4 | 174 | 2 | GO:0070532 | |
| GeneOntologyCellularComponent | synaptonemal complex | 5.76e-04 | 46 | 174 | 4 | GO:0000795 | |
| GeneOntologyCellularComponent | synaptonemal structure | 5.76e-04 | 46 | 174 | 4 | GO:0099086 | |
| GeneOntologyCellularComponent | motile cilium | TEKT3 CCDC39 CEP164 FSIP2 CFAP70 CCDC65 DNAH8 PMFBP1 PCNT DNAH11 | 8.10e-04 | 355 | 174 | 10 | GO:0031514 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 8.80e-04 | 238 | 174 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | cytoplasmic region | TEKT3 RIBC2 CENPF CCDC39 PIK3R4 DST CFAP70 CCDC65 DNAH8 DNAH11 | 9.01e-04 | 360 | 174 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 9.85e-04 | 91 | 174 | 5 | GO:0000794 | |
| GeneOntologyCellularComponent | BRCA1-C complex | 1.01e-03 | 6 | 174 | 2 | GO:0070533 | |
| GeneOntologyCellularComponent | dynein complex | 1.06e-03 | 54 | 174 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.14e-03 | 25 | 174 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | myosin filament | 1.14e-03 | 25 | 174 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.59e-03 | 28 | 174 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | pericentriolar material | 1.59e-03 | 28 | 174 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | chromosomal region | MIS18BP1 CENPF SMC1A GATAD2B RAD50 SYCP2 BRCA2 PDS5A UHRF2 KNL1 | 2.85e-03 | 421 | 174 | 10 | GO:0098687 |
| GeneOntologyCellularComponent | ciliary transition fiber | 2.97e-03 | 10 | 174 | 2 | GO:0097539 | |
| HumanPheno | Sloping forehead | BRIP1 CEP290 CCDC88A BRCA1 BRCA2 ASXL3 CEP135 UGP2 SASS6 CDK5RAP2 CEP295 KNL1 PCNT | 9.17e-08 | 188 | 57 | 13 | HP:0000340 |
| HumanPheno | Decreased fertility | TEKT3 TBX3 BRIP1 SDCCAG8 CEP290 CCDC141 CCDC39 FSIP2 SYCP2 BRCA1 BRCA2 CFAP70 CCDC65 DNAH8 PMFBP1 DNAH11 | 2.27e-06 | 380 | 57 | 16 | HP:0000144 |
| HumanPheno | Decreased fertility in males | TEKT3 BRIP1 CCDC39 FSIP2 SYCP2 BRCA1 BRCA2 CFAP70 CCDC65 DNAH8 PMFBP1 DNAH11 | 8.16e-06 | 236 | 57 | 12 | HP:0012041 |
| HumanPheno | Primary peritoneal carcinoma | 1.30e-05 | 14 | 57 | 4 | HP:0030406 | |
| HumanPheno | Abnormal sperm motility | 3.47e-05 | 115 | 57 | 8 | HP:0012206 | |
| HumanPheno | Abnormal sperm physiology | 3.47e-05 | 115 | 57 | 8 | HP:0034809 | |
| HumanPheno | Upslanted palpebral fissure | BRIP1 SMC1A GATAD2B JARID2 BRCA1 BRCA2 ASXL3 CEP135 SASS6 CDK5RAP2 CEP295 KNL1 PCNT | 5.56e-05 | 333 | 57 | 13 | HP:0000582 |
| HumanPheno | Infertility | TEKT3 SDCCAG8 CEP290 CCDC141 CCDC39 FSIP2 SYCP2 CFAP70 CCDC65 DNAH8 PMFBP1 DNAH11 | 1.39e-04 | 314 | 57 | 12 | HP:0000789 |
| MousePheno | abnormal cell nucleus morphology | BRIP1 ATAD5 CEP290 EPB41L5 BRCA1 BRCA2 RBM19 SYNE2 CEP135 CDK5RAP2 | 9.53e-06 | 184 | 132 | 10 | MP:0003111 |
| MousePheno | abnormal centrosome morphology | 3.27e-05 | 20 | 132 | 4 | MP:0030943 | |
| MousePheno | abnormal microtubule organizing center morphology | 4.87e-05 | 22 | 132 | 4 | MP:0030942 | |
| MousePheno | abnormal microtubule cytoskeleton morphology | 6.99e-05 | 46 | 132 | 5 | MP:0020850 | |
| MousePheno | abnormal cell cytoskeleton morphology | 7.47e-05 | 75 | 132 | 6 | MP:0020378 | |
| MousePheno | transposition of great arteries | 7.76e-05 | 47 | 132 | 5 | MP:0004110 | |
| MousePheno | absent kidney epithelial cell primary cilium | 8.85e-05 | 2 | 132 | 2 | MP:0020384 | |
| MousePheno | abnormal brain development | YBX1 CEP290 PFDN1 CCDC39 CEP164 RAD50 CCDC88A BRD2 BRCA1 EGFR CEP135 SASS6 CDK5RAP2 CFAP70 CAMSAP1 CCDC65 PCNT | 1.05e-04 | 638 | 132 | 17 | MP:0000913 |
| MousePheno | atrioventricular septal defect | 1.41e-04 | 84 | 132 | 6 | MP:0010412 | |
| MousePheno | abnormal atrioventricular septum morphology | 1.71e-04 | 87 | 132 | 6 | MP:0010592 | |
| Domain | zf-C2H2 | ZNF569 ZNF391 ZNF273 ZNF407 ZHX2 YY1 ZNF568 ZUP1 ZNF675 ZNF430 ZNF514 ZNF594 ZNF544 ZNF684 ZNF41 ZBTB40 ZNF770 ZNF85 ZNF91 ZNF730 ZNF286A | 3.68e-07 | 693 | 157 | 21 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF569 ZNF391 ZNF273 ZNF407 ZHX2 YY1 ZNF568 ZUP1 ZNF675 ZNF430 ZNF514 ZNF594 ZNF544 ZNF684 ZNF41 ZBTB40 ZNF770 ZNF85 EEA1 ZNF91 ZNF730 ZNF286A | 5.71e-07 | 775 | 157 | 22 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF569 ZNF391 ZNF273 ZNF407 ZHX2 YY1 ZNF568 ZUP1 ZNF675 ZNF430 ZNF514 ZNF594 ZNF544 ZNF684 ZNF41 ZBTB40 ZNF770 ZNF85 EEA1 ZNF91 ZNF730 ZNF286A | 5.96e-07 | 777 | 157 | 22 | PS00028 |
| Domain | Znf_C2H2-like | ZNF569 ZNF391 ZNF273 ZNF407 ZHX2 YY1 ZNF568 ZUP1 ZNF675 ZNF430 ZNF514 ZNF594 ZNF544 ZNF684 ZNF41 ZBTB40 ZNF770 ZNF85 EEA1 ZNF91 ZNF730 ZNF286A | 8.92e-07 | 796 | 157 | 22 | IPR015880 |
| Domain | Znf_C2H2 | ZNF569 ZNF391 ZNF273 ZNF407 ZHX2 YY1 ZNF568 ZUP1 ZNF675 ZNF430 ZNF514 ZNF594 ZNF544 ZNF684 ZNF41 ZBTB40 ZNF770 ZNF85 EEA1 ZNF91 ZNF730 ZNF286A | 1.08e-06 | 805 | 157 | 22 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF569 ZNF391 ZNF273 ZNF407 ZHX2 YY1 ZNF568 ZUP1 ZNF675 ZNF430 ZNF514 ZNF594 ZNF544 ZNF684 ZNF41 ZBTB40 ZNF770 ZNF85 EEA1 ZNF91 ZNF730 ZNF286A | 1.14e-06 | 808 | 157 | 22 | SM00355 |
| Domain | Spectrin | 1.17e-06 | 23 | 157 | 5 | PF00435 | |
| Domain | Spectrin_repeat | 3.97e-06 | 29 | 157 | 5 | IPR002017 | |
| Domain | - | ZNF569 ZNF391 ZNF273 ZNF407 YY1 ZNF568 ZNF675 ZNF430 ZNF514 ZNF594 ZNF544 ZNF684 ZNF41 ZBTB40 ZNF770 ZNF85 ZNF91 ZNF730 ZNF286A | 4.44e-06 | 679 | 157 | 19 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF569 ZNF391 ZNF273 ZNF407 YY1 ZNF568 ZNF675 ZNF430 ZNF514 ZNF594 ZNF544 ZNF684 ZNF41 ZBTB40 ZNF770 ZNF85 ZNF91 ZNF730 ZNF286A | 6.07e-06 | 694 | 157 | 19 | IPR013087 |
| Domain | KRAB | ZNF569 ZNF273 ZNF568 ZNF675 ZNF430 ZNF514 ZNF544 ZNF684 ZNF41 ZNF85 ZNF91 ZNF730 ZNF286A | 1.07e-05 | 358 | 157 | 13 | PS50805 |
| Domain | KRAB | ZNF569 ZNF273 ZNF568 ZNF675 ZNF430 ZNF514 ZNF544 ZNF684 ZNF41 ZNF85 ZNF91 ZNF730 ZNF286A | 1.07e-05 | 358 | 157 | 13 | PF01352 |
| Domain | zf-C2H2_6 | ZNF569 ZNF391 ZNF273 ZNF568 ZNF675 ZNF514 ZNF684 ZNF770 ZNF85 ZNF91 ZNF730 ZNF286A | 1.43e-05 | 314 | 157 | 12 | PF13912 |
| Domain | KRAB | ZNF569 ZNF273 ZNF568 ZNF675 ZNF430 ZNF514 ZNF544 ZNF684 ZNF41 ZNF85 ZNF91 ZNF730 ZNF286A | 1.48e-05 | 369 | 157 | 13 | SM00349 |
| Domain | KRAB | ZNF569 ZNF273 ZNF568 ZNF675 ZNF430 ZNF514 ZNF544 ZNF684 ZNF41 ZNF85 ZNF91 ZNF730 ZNF286A | 1.52e-05 | 370 | 157 | 13 | IPR001909 |
| Domain | Myosin_head_motor_dom | 1.58e-05 | 38 | 157 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.58e-05 | 38 | 157 | 5 | PS51456 | |
| Domain | Myosin_head | 1.58e-05 | 38 | 157 | 5 | PF00063 | |
| Domain | MYSc | 1.58e-05 | 38 | 157 | 5 | SM00242 | |
| Domain | SPEC | 1.44e-04 | 32 | 157 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.44e-04 | 32 | 157 | 4 | IPR018159 | |
| Domain | Myosin_N | 2.46e-04 | 15 | 157 | 3 | PF02736 | |
| Domain | Myosin_N | 2.46e-04 | 15 | 157 | 3 | IPR004009 | |
| Domain | SHR-BD | 4.17e-04 | 4 | 157 | 2 | IPR009543 | |
| Domain | VPS13_C | 4.17e-04 | 4 | 157 | 2 | PF16909 | |
| Domain | VPS13_C | 4.17e-04 | 4 | 157 | 2 | IPR031645 | |
| Domain | SHR-BD | 4.17e-04 | 4 | 157 | 2 | PF06650 | |
| Domain | Myosin_tail_1 | 4.33e-04 | 18 | 157 | 3 | PF01576 | |
| Domain | Myosin_tail | 4.33e-04 | 18 | 157 | 3 | IPR002928 | |
| Domain | Znf_RING_CS | 4.62e-04 | 163 | 157 | 7 | IPR017907 | |
| Domain | Myosin-like_IQ_dom | 5.11e-04 | 19 | 157 | 3 | IPR027401 | |
| Domain | - | 5.11e-04 | 19 | 157 | 3 | 4.10.270.10 | |
| Domain | IQ | 6.03e-04 | 81 | 157 | 5 | SM00015 | |
| Domain | Autophagy-rel_C | 6.91e-04 | 5 | 157 | 2 | IPR015412 | |
| Domain | ATG_C | 6.91e-04 | 5 | 157 | 2 | PF09333 | |
| Domain | ACTININ_2 | 9.12e-04 | 23 | 157 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.12e-04 | 23 | 157 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.12e-04 | 23 | 157 | 3 | IPR001589 | |
| Domain | IQ_motif_EF-hand-BS | 9.74e-04 | 90 | 157 | 5 | IPR000048 | |
| Domain | IQ | 1.13e-03 | 93 | 157 | 5 | PS50096 | |
| Domain | Myosin_TH1 | 1.43e-03 | 7 | 157 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 1.43e-03 | 7 | 157 | 2 | IPR010926 | |
| Domain | TH1 | 1.43e-03 | 7 | 157 | 2 | PS51757 | |
| Domain | Chorein_N | 1.90e-03 | 8 | 157 | 2 | PF12624 | |
| Domain | DHC_N1 | 1.90e-03 | 8 | 157 | 2 | PF08385 | |
| Domain | VPS13_N | 1.90e-03 | 8 | 157 | 2 | IPR026854 | |
| Domain | RecF/RecN/SMC_N | 1.90e-03 | 8 | 157 | 2 | IPR003395 | |
| Domain | SMC_N | 1.90e-03 | 8 | 157 | 2 | PF02463 | |
| Domain | Dynein_heavy_dom-1 | 1.90e-03 | 8 | 157 | 2 | IPR013594 | |
| Domain | P-loop_NTPase | MYH1 MYH4 BRIP1 MYO1D ATAD5 MYH7B SMC1A MYO1B RFC1 DHX8 RAD50 NLRP10 TRANK1 RECQL5 DNAH8 DNAH11 | 2.12e-03 | 848 | 157 | 16 | IPR027417 |
| Domain | SH3 | 2.37e-03 | 216 | 157 | 7 | PS50002 | |
| Domain | SH3_domain | 2.63e-03 | 220 | 157 | 7 | IPR001452 | |
| Domain | SH3_1 | 2.66e-03 | 164 | 157 | 6 | PF00018 | |
| Pathway | REACTOME_CELL_CYCLE | BRIP1 MIS18BP1 CENPF SMC1A SDCCAG8 CEP290 RFC1 ESCO1 CEP164 RAD50 SYCP2 BRCA1 BRCA2 SYNE2 CEP135 CDK5RAP2 PDS5A KNL1 PCNT | 4.66e-06 | 694 | 118 | 19 | M543 |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 5.02e-06 | 81 | 118 | 7 | M39490 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | CENPF SMC1A SDCCAG8 CEP290 CEP164 CEP135 CDK5RAP2 PDS5A KNL1 PCNT | 8.10e-06 | 204 | 118 | 10 | M4217 |
| Pathway | BIOCARTA_EEA1_PATHWAY | 1.95e-05 | 7 | 118 | 3 | M22064 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 3.02e-05 | 72 | 118 | 6 | M27749 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 5.89e-05 | 81 | 118 | 6 | M748 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 6.05e-05 | 26 | 118 | 4 | MM15297 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA | 7.05e-05 | 27 | 118 | 4 | M27586 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 8.80e-05 | 87 | 118 | 6 | M27194 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 8.98e-05 | 11 | 118 | 3 | M27177 | |
| Pathway | WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 8.98e-05 | 11 | 118 | 3 | M42562 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 8.98e-05 | 11 | 118 | 3 | MM14891 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 1.32e-04 | 59 | 118 | 5 | MM15283 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.43e-04 | 95 | 118 | 6 | M6729 | |
| Pathway | WP_CILIOPATHIES | 1.56e-04 | 184 | 118 | 8 | M39880 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 1.61e-04 | 97 | 118 | 6 | M27478 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 2.00e-04 | 35 | 118 | 4 | MM15293 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 2.49e-04 | 37 | 118 | 4 | M27583 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 2.94e-04 | 202 | 118 | 8 | MM15362 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR | 2.96e-04 | 16 | 118 | 3 | M47855 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 2.96e-04 | 70 | 118 | 5 | M27570 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 3.16e-04 | 71 | 118 | 5 | MM15495 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 4.47e-04 | 43 | 118 | 4 | M27588 | |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 5.02e-04 | 19 | 118 | 3 | MM1478 | |
| Pathway | REACTOME_CELL_CYCLE | BRIP1 MIS18BP1 CENPF SMC1A SDCCAG8 CEP290 RFC1 ESCO1 CEP164 RAD50 BRCA1 CEP135 CDK5RAP2 PDS5A | 5.09e-04 | 603 | 118 | 14 | MM14635 |
| Pathway | REACTOME_MEIOSIS | 5.09e-04 | 120 | 118 | 6 | M529 | |
| Pathway | PID_FANCONI_PATHWAY | 6.30e-04 | 47 | 118 | 4 | M1 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 7.26e-04 | 85 | 118 | 5 | MM14906 | |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 7.84e-04 | 22 | 118 | 3 | M9703 | |
| Pathway | REACTOME_DISEASES_OF_DNA_REPAIR | 8.61e-04 | 51 | 118 | 4 | M29854 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 9.41e-04 | 90 | 118 | 5 | MM14979 | |
| Pathway | BIOCARTA_EEA1_PATHWAY | 1.02e-03 | 6 | 118 | 2 | MM1577 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 1.14e-03 | 55 | 118 | 4 | M39598 | |
| Pubmed | CYLC1 CACNA1E MYH1 MYH4 MYO1D CENPF YBX1 MYH7B SPTA1 ITSN1 KTN1 CCDC150 RDX MYO1B CTAGE6 YY1 CHUK PCF11 ZNF675 DST BRD2 BRCA1 AP2A2 SYNE2 CTAGE8 UGP2 CTAGE15 CEP295 EEA1 CTAGE4 DNAH8 PCNT | 3.30e-12 | 1442 | 180 | 32 | 35575683 | |
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 5.36e-11 | 26 | 180 | 7 | 14654843 | |
| Pubmed | TRAF5 CEP85 SDCCAG8 CEP290 CEP164 CEP170 CEP135 SASS6 CDK5RAP2 CEP295 PCNT | 3.13e-10 | 146 | 180 | 11 | 21399614 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RNF169 BRIP1 MIS18BP1 ATAD5 SMC1A RFC1 YY1 GATAD2B DHX8 FSIP2 BRD2 BRCA1 RECQL5 ZBTB40 PDS5A ZNF770 SCAF11 UHRF2 ILKAP | 4.92e-10 | 608 | 180 | 19 | 36089195 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | CENPF ITSN1 APBA2 GATAD2B CEP170 CCDC88A DST ZNF544 CEP135 COBL | 7.61e-10 | 120 | 180 | 10 | 31413325 |
| Pubmed | RNF169 SMC1A KTN1 CEP290 EPB41L5 ZNF407 BIRC6 ESCO1 SHANK3 GATAD2B PCF11 CEP170 AP2A2 CEP135 PDS5A FHDC1 ZNF286A | 9.69e-10 | 493 | 180 | 17 | 15368895 | |
| Pubmed | RNF169 BRIP1 VPS13C ITSN1 KTN1 CEP290 EPB41L5 YY1 BIRC6 GATAD2B DHX8 ITPR2 CEP170 CCDC88A CEP135 CEP295 TRIM13 CAMSAP1 NCK2 KNL1 | 1.74e-09 | 733 | 180 | 20 | 34672954 | |
| Pubmed | Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. | 2.70e-09 | 12 | 180 | 5 | 16391231 | |
| Pubmed | BRIP1 CEP85 CENPF ITSN1 EPB41L5 DHX8 RAD50 CEP170 DST BAIAP2L1 ZC3H4 SERPINB3 SASS6 CAMSAP1 KNL1 ILKAP | 3.93e-09 | 472 | 180 | 16 | 38943005 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RNF169 BRIP1 YBX1 ATAD5 SMC1A KTN1 BUD13 RFC1 YY1 GATAD2B PCF11 CEP170 BRD2 BRCA1 BRCA2 ZC3H4 RBM19 RECQL5 PDS5A SCAF11 KNL1 ILKAP | 5.54e-09 | 954 | 180 | 22 | 36373674 |
| Pubmed | 2.40e-08 | 7 | 180 | 4 | 21356067 | ||
| Pubmed | RNF169 BRIP1 MIS18BP1 SMC1A RAD50 BRD2 BRCA1 AP2A2 BRCA2 RECQL5 PDS5A | 2.57e-08 | 222 | 180 | 11 | 37071664 | |
| Pubmed | YBX1 SMC1A LEKR1 CEP290 RB1CC1 RFC1 CCDC141 BIRC6 GATAD2B RAD50 JARID2 BRD2 ZC3H4 PDS5A SCAF11 | 2.64e-08 | 469 | 180 | 15 | 27634302 | |
| Pubmed | SMC1A GIT2 BIRC6 DST AP2A2 ZC3H4 SYNE2 ZBTB40 AKAP11 ZNF286A PCNT | 2.94e-08 | 225 | 180 | 11 | 12168954 | |
| Pubmed | RNF169 CEP85 MYO1D ATAD5 CEP290 MYO1B RB1CC1 BIRC6 ITPR2 PCF11 CCDC88A BRD2 EGFR SYNE2 CEP135 CDK5RAP2 TRIM13 UTRN NCK2 KNL1 PCNT ILKAP | 3.00e-08 | 1049 | 180 | 22 | 27880917 | |
| Pubmed | 3.85e-08 | 19 | 180 | 5 | 24421332 | ||
| Pubmed | A Conserved Role for Girdin in Basal Body Positioning and Ciliogenesis. | 4.78e-08 | 8 | 180 | 4 | 27623382 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MIS18BP1 CEP85 MYO1D ITSN1 MYO1B PFDN1 GIT2 RAD50 CCDC88A BAIAP2L1 BRCA2 RECQL5 SASS6 NCK2 KNL1 PCNT | 8.28e-08 | 588 | 180 | 16 | 38580884 |
| Pubmed | 1.36e-07 | 3 | 180 | 3 | 29726012 | ||
| Pubmed | Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. | 1.36e-07 | 3 | 180 | 3 | 26824983 | |
| Pubmed | 2.23e-07 | 11 | 180 | 4 | 19584272 | ||
| Pubmed | SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. | 2.23e-07 | 11 | 180 | 4 | 11877377 | |
| Pubmed | RNF169 MIS18BP1 ATAD5 CEP290 GIT2 RFC1 RAD50 CEP170 DST BRD2 BRCA1 RECQL5 CEP135 CAMSAP1 UTRN PCNT | 2.87e-07 | 645 | 180 | 16 | 25281560 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYO1B RB1CC1 GATAD2B CHUK ITPR2 RAD50 PIK3R4 CEP170 DST BRD2 AP2A2 EGFR ZC3H4 CDK5RAP2 AKAP11 UTRN NCK2 KNL1 | 3.00e-07 | 910 | 180 | 19 | 36736316 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 MYH4 CENPF VPS13C ITSN1 KTN1 CEP290 BIRC6 ESCO1 CCDC39 ITPR2 ZNF675 DST PDS5A CEP295 C6 UTRN | 3.26e-07 | 736 | 180 | 17 | 29676528 |
| Pubmed | SMC1A KTN1 RDX ZNF407 GIT2 CCDC141 BIRC6 CEP170 DST SYNE2 UGP2 ZBTB40 CDK5RAP2 UTRN | 3.64e-07 | 497 | 180 | 14 | 23414517 | |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 4.78e-07 | 13 | 180 | 4 | 17920017 | |
| Pubmed | TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. | 5.35e-07 | 31 | 180 | 5 | 26095369 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIS18BP1 MYO1D VPS13C ITSN1 SDCCAG8 CEP290 PFDN1 CEP164 RAD50 CCDC88A BAIAP2L1 BRCA2 CEP135 SASS6 COBL CEP295 CAMSAP1 PCNT | 5.37e-07 | 853 | 180 | 18 | 28718761 |
| Pubmed | 6.67e-07 | 14 | 180 | 4 | 32060285 | ||
| Pubmed | CACNA1E CENPF ITSN1 KTN1 RAPGEF4 RDX GIT2 SHANK3 GATAD2B RAD50 CEP170 CCDC88A DST AP2A2 ZC3H4 SYNE2 CDK5RAP2 CAMSAP1 PCNT | 7.01e-07 | 963 | 180 | 19 | 28671696 | |
| Pubmed | 7.41e-07 | 33 | 180 | 5 | 19714462 | ||
| Pubmed | RNF169 BRIP1 CENPF ATAD5 ZHX2 IFI16 RAD50 FAM111A BRCA1 BRCA2 ZC3H4 RECQL5 KNL1 | 7.85e-07 | 453 | 180 | 13 | 29656893 | |
| Pubmed | SMC1A GIT2 BIRC6 TMCC3 CCDC88A SYNE2 CDK5RAP2 AKAP11 CAMSAP1 CCDC93 | 8.36e-07 | 251 | 180 | 10 | 29778605 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 9.69e-07 | 197 | 180 | 9 | 20811636 | |
| Pubmed | 1.01e-06 | 101 | 180 | 7 | 26949739 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TBX3 RNF169 CENPF ATAD5 SMC1A SPTA1 KTN1 CEP290 RFC1 IFI16 YY1 ESCO1 GATAD2B DHX8 RAD50 SINHCAF DST BRD2 BRCA1 RECQL5 PDS5A SCAF11 | 1.07e-06 | 1294 | 180 | 22 | 30804502 |
| Pubmed | 1.18e-06 | 149 | 180 | 8 | 25184681 | ||
| Pubmed | 1.30e-06 | 151 | 180 | 8 | 17043677 | ||
| Pubmed | TRPC4AP MYO1D ATAD5 KTN1 PFDN1 RFC1 ZNF568 EXD3 SINHCAF ASXL3 SYNE2 CDK5RAP2 CEP295 KNL1 DNAH11 | 1.33e-06 | 638 | 180 | 15 | 31182584 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.35e-06 | 5 | 180 | 3 | 12629516 | |
| Pubmed | Fanconi anemia group J helicase and MRE11 nuclease interact to facilitate the DNA damage response. | 1.35e-06 | 5 | 180 | 3 | 23530059 | |
| Pubmed | 1.35e-06 | 5 | 180 | 3 | 17664283 | ||
| Pubmed | CEP85 MYO1D YBX1 ATAD5 SMC1A MYO1B PFDN1 RFC1 ZHX2 YY1 GATAD2B RAD50 PCF11 SINHCAF DST BRD2 BRCA1 RECQL5 SYNE2 ZBTB40 PDS5A ZNF770 SCAF11 | 1.51e-06 | 1429 | 180 | 23 | 35140242 | |
| Pubmed | 1.92e-06 | 159 | 180 | 8 | 30581152 | ||
| Pubmed | 2.01e-06 | 18 | 180 | 4 | 18664271 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TRPC4AP CENPF YBX1 SMC1A AGGF1 BUD13 PFDN1 TF ESCO1 PCF11 CEP170 HP ZC3H4 CEP135 SASS6 CDK5RAP2 PDS5A EEA1 VPS13B KNL1 | 2.60e-06 | 1155 | 180 | 20 | 20360068 |
| Pubmed | PALB2 is an integral component of the BRCA complex required for homologous recombination repair. | 2.70e-06 | 6 | 180 | 3 | 19369211 | |
| Pubmed | NBS1 prevents chromatid-type aberrations through ATM-dependent interactions with SMC1. | 2.70e-06 | 6 | 180 | 3 | 18763866 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RNF169 BRIP1 SMC1A ITSN1 BUD13 RFC1 IFI16 YY1 GATAD2B RAD50 PCF11 BRD2 EGFR ZC3H4 ZBTB40 SCAF11 | 3.08e-06 | 774 | 180 | 16 | 15302935 |
| Pubmed | SMC1A KTN1 MYO1B GIT2 RFC1 IFI16 YY1 RAD50 CEP170 BRD2 SRGAP1 SCAF11 EEA1 UHRF2 | 3.38e-06 | 601 | 180 | 14 | 33658012 | |
| Pubmed | BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer | 3.88e-06 | 21 | 180 | 4 | 20301425 | |
| Pubmed | VPS13C ERI2 NACAD CCDC88A TRANK1 DST ZC3H4 SULF1 CDK5RAP2 AKAP11 SCAF11 KDM7A SYT13 | 4.30e-06 | 529 | 180 | 13 | 14621295 | |
| Pubmed | 4.70e-06 | 7 | 180 | 3 | 16632484 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO1D CENPF YBX1 SMC1A CEP290 MYO1B RB1CC1 DHX8 ITPR2 RAD50 CEP170 DST BRD2 ZC3H4 SYNE2 EEA1 UTRN PCNT | 6.91e-06 | 1024 | 180 | 18 | 24711643 |
| Pubmed | 7.49e-06 | 8 | 180 | 3 | 23585894 | ||
| Pubmed | MYO1D CENPF MYO1B RFC1 BIRC6 DHX8 RAD50 CEP170 DST SYNE2 PDS5A SCAF11 UTRN PCNT | 8.66e-06 | 653 | 180 | 14 | 22586326 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO1D CENPF YBX1 SMC1A BUD13 MYO1B RFC1 IFI16 DHX8 ITPR2 RAD50 CEP170 DST BAIAP2L1 EGFR SERPINB3 RBM19 SRGAP1 SCAF11 UHRF2 | 9.06e-06 | 1257 | 180 | 20 | 36526897 |
| Pubmed | MIS18BP1 ITSN1 APBA2 EPB41L5 CCDC88A TRIM13 CAMSAP1 UTRN VPS13B | 1.02e-05 | 263 | 180 | 9 | 34702444 | |
| Pubmed | The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. | 1.08e-05 | 56 | 180 | 5 | 11076968 | |
| Pubmed | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | 1.11e-05 | 27 | 180 | 4 | 17525332 | |
| Pubmed | Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance. | 1.12e-05 | 9 | 180 | 3 | 28398198 | |
| Pubmed | 1.12e-05 | 9 | 180 | 3 | 26269593 | ||
| Pubmed | The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. | 1.18e-05 | 57 | 180 | 5 | 16462731 | |
| Pubmed | 1.23e-05 | 340 | 180 | 10 | 24332808 | ||
| Pubmed | CENPF RB1CC1 BIRC6 RAD50 CCDC88A DST BRCA2 CAMSAP1 UTRN KNL1 PCNT | 1.27e-05 | 418 | 180 | 11 | 34709266 | |
| Pubmed | Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. | 1.29e-05 | 58 | 180 | 5 | 12852856 | |
| Pubmed | YBX1 VPS13C EPB41L5 BIRC6 PCF11 CCDC88A DST BRCA1 BAIAP2L1 EGFR ZC3H4 RBM19 CDK5RAP2 PDS5A CAMSAP1 | 1.42e-05 | 777 | 180 | 15 | 35844135 | |
| Pubmed | Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. | 1.49e-05 | 101 | 180 | 6 | 20587610 | |
| Pubmed | Sororin mediates sister chromatid cohesion by antagonizing Wapl. | 1.59e-05 | 10 | 180 | 3 | 21111234 | |
| Pubmed | 1.65e-05 | 61 | 180 | 5 | 7790358 | ||
| Pubmed | YBX1 SMC1A PFDN1 RFC1 IFI16 YY1 GATAD2B CCDC7 RAD50 PCF11 CEP170 BRCA1 ZBTB40 PDS5A ZNF770 UHRF2 ZNF286A KNL1 | 1.87e-05 | 1103 | 180 | 18 | 34189442 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.88e-05 | 157 | 180 | 7 | 30686591 | |
| Pubmed | 1.96e-05 | 31 | 180 | 4 | 19690177 | ||
| Pubmed | 2.18e-05 | 11 | 180 | 3 | 1679528 | ||
| Pubmed | 2.18e-05 | 11 | 180 | 3 | 12607005 | ||
| Pubmed | 2.23e-05 | 32 | 180 | 4 | 20301301 | ||
| Pubmed | 2.43e-05 | 66 | 180 | 5 | 12221128 | ||
| Pubmed | RNF169 SMC1A ITSN1 RDX PFDN1 GIT2 YY1 CEP170 ARHGAP6 AP2A2 SERPINB3 SRGAP1 COBL PDS5A ARHGEF3 UTRN | 2.47e-05 | 916 | 180 | 16 | 32203420 | |
| Pubmed | Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis. | 2.66e-05 | 2 | 180 | 2 | 29480828 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 17924331 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12833555 | ||
| Pubmed | Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. | 2.66e-05 | 2 | 180 | 2 | 14735173 | |
| Pubmed | Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. | 2.66e-05 | 2 | 180 | 2 | 16032702 | |
| Pubmed | Oral contraceptive use and BRCA penetrance: a case-only study. | 2.66e-05 | 2 | 180 | 2 | 19549808 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 34101484 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 26961146 | ||
| Pubmed | Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study. | 2.66e-05 | 2 | 180 | 2 | 20512419 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 37804357 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22053997 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 29044548 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 33834176 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 18200524 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 29298688 | ||
| Pubmed | Fertility in women with BRCA mutations: a case-control study. | 2.66e-05 | 2 | 180 | 2 | 19200971 | |
| Pubmed | Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. | 2.66e-05 | 2 | 180 | 2 | 16030099 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 28212807 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11448436 | ||
| Pubmed | Rapid evolution of BRCA1 and BRCA2 in humans and other primates. | 2.66e-05 | 2 | 180 | 2 | 25011685 | |
| Pubmed | Breast magnetic resonance imaging for screening high-risk women. | 2.66e-05 | 2 | 180 | 2 | 23928241 | |
| Interaction | NDC80 interactions | CEP85 SMC1A CEP290 PFDN1 BIRC6 CEP164 RAD50 EGFR SYNE2 CEP135 CDK5RAP2 CEP295 CAMSAP1 KNL1 PCNT | 7.29e-08 | 312 | 171 | 15 | int:NDC80 |
| Interaction | HDAC1 interactions | MYH1 MYH4 TBX3 CENPF ZNF273 SMC1A PFDN1 RB1CC1 RFC1 ZHX2 YY1 BIRC6 ESCO1 GATAD2B RAD50 SINHCAF DST BRCA1 BRCA2 EGFR SYNE2 CEP135 CDK5RAP2 CAMSAP1 UHRF2 UTRN KNL1 PCNT | 2.05e-07 | 1108 | 171 | 28 | int:HDAC1 |
| Interaction | CEP43 interactions | CEP290 ESCO1 RAD50 PIK3R4 CEP170 BRCA1 CEP135 SASS6 CDK5RAP2 AKAP11 CEP295 | 6.97e-07 | 190 | 171 | 11 | int:CEP43 |
| Interaction | CTAGE1 interactions | 1.01e-06 | 10 | 171 | 4 | int:CTAGE1 | |
| Interaction | SMC5 interactions | MYH1 MYH4 RNF169 BRIP1 YBX1 ATAD5 SMC1A KTN1 BUD13 RFC1 YY1 GATAD2B RAD50 PCF11 CEP170 BRD2 BRCA1 BRCA2 ZC3H4 RBM19 RECQL5 PDS5A SCAF11 KNL1 ILKAP | 1.21e-06 | 1000 | 171 | 25 | int:SMC5 |
| Interaction | TRIM52 interactions | BRIP1 MIS18BP1 CEP290 CEP164 CCDC88A BRCA2 CDK5RAP2 CEP295 PCNT | 2.04e-06 | 133 | 171 | 9 | int:TRIM52 |
| Interaction | EXOC1 interactions | 3.72e-06 | 143 | 171 | 9 | int:EXOC1 | |
| Interaction | CEP135 interactions | CEP85 CEP290 CEP164 CEP170 CCDC88A BRCA2 CEP135 SASS6 CDK5RAP2 CEP295 CAMSAP1 PCNT | 3.76e-06 | 272 | 171 | 12 | int:CEP135 |
| Interaction | PCM1 interactions | MIS18BP1 CEP85 CEP290 RB1CC1 CEP164 CEP170 SRGAP1 CEP135 SASS6 CDK5RAP2 CEP295 EEA1 CAMSAP1 CCDC65 PCNT | 4.64e-06 | 434 | 171 | 15 | int:PCM1 |
| Interaction | H3C3 interactions | RNF169 BRIP1 MIS18BP1 ATAD5 SMC1A RFC1 YY1 GATAD2B DHX8 FSIP2 BRD2 BRCA1 RECQL5 PDS5A SCAF11 UHRF2 | 5.18e-06 | 495 | 171 | 16 | int:H3C3 |
| Interaction | PARP1 interactions | RNF169 YBX1 ATAD5 SMC1A SPTA1 ARMC10 DTX3L RB1CC1 RFC1 IFI16 YY1 GATAD2B RAD50 PIK3R4 CEP170 BRD2 BRCA1 AP2A2 BRCA2 EGFR RBM19 RECQL5 CDK5RAP2 PDS5A SCAF11 EEA1 UHRF2 ILKAP | 5.99e-06 | 1316 | 171 | 28 | int:PARP1 |
| Interaction | NUP43 interactions | BRIP1 MIS18BP1 SMC1A BUD13 RFC1 ZHX2 IFI16 DHX8 FSIP2 CCDC88A DST BRCA1 BRCA2 EGFR RBM19 RECQL5 SYNE2 KNL1 | 6.46e-06 | 625 | 171 | 18 | int:NUP43 |
| Interaction | CALM1 interactions | TBX3 MYO1D YBX1 VPS13C CEP290 RDX MYO1B CAMK1 ESCO1 CCDC88A DST EGFR SYNE2 CDK5RAP2 SCAF11 TRIM13 UTRN PCNT | 6.61e-06 | 626 | 171 | 18 | int:CALM1 |
| Interaction | BUB1B interactions | MIS18BP1 CENPF DHX8 ITPR2 BRCA2 EGFR SERPINB3 UGP2 CEP295 KNL1 | 6.68e-06 | 195 | 171 | 10 | int:BUB1B |
| Interaction | CBX3 interactions | RNF169 BRIP1 MIS18BP1 ATAD5 RFC1 IFI16 YY1 ZNF568 DHX8 BRD2 BRCA1 EGFR ZC3H4 PDS5A ZNF91 UHRF2 KNL1 ILKAP | 1.01e-05 | 646 | 171 | 18 | int:CBX3 |
| Interaction | CCDC175 interactions | 1.18e-05 | 6 | 171 | 3 | int:CCDC175 | |
| Interaction | INSYN1 interactions | 1.44e-05 | 169 | 171 | 9 | int:INSYN1 | |
| Interaction | BORCS6 interactions | KTN1 CCDC122 CEP164 CEP170 CEP135 SASS6 CDK5RAP2 CAMSAP1 PCNT | 1.51e-05 | 170 | 171 | 9 | int:BORCS6 |
| Interaction | CETN1 interactions | 1.56e-05 | 63 | 171 | 6 | int:CETN1 | |
| Interaction | CEP170 interactions | CEP290 RB1CC1 IFI16 CEP170 BRD2 BRCA1 EGFR SYNE2 CEP135 SASS6 CAMSAP1 NCK2 | 1.82e-05 | 318 | 171 | 12 | int:CEP170 |
| Interaction | H3-3A interactions | RNF169 BRIP1 ATAD5 SMC1A RFC1 YY1 GATAD2B DHX8 RAD50 BRD2 BRCA1 EGFR RECQL5 ZBTB40 PDS5A ZNF770 SCAF11 UHRF2 ILKAP | 2.11e-05 | 749 | 171 | 19 | int:H3-3A |
| Interaction | HERC2 interactions | KTN1 CEP290 APBA2 RB1CC1 BIRC6 ITPR2 CEP170 CCDC88A DST BRCA1 EGFR SYNE2 CEP135 CCDC65 ZNF286A | 2.65e-05 | 503 | 171 | 15 | int:HERC2 |
| Interaction | SNRNP40 interactions | BRIP1 MIS18BP1 ATAD5 AGGF1 BUD13 PFDN1 RFC1 ZHX2 YY1 DHX8 BRCA1 BRCA2 EGFR ZC3H4 RECQL5 SCAF11 KNL1 | 3.12e-05 | 637 | 171 | 17 | int:SNRNP40 |
| Interaction | TERF2 interactions | CENPF YY1 RAD50 DST BRD2 BRCA1 AP2A2 BAIAP2L1 BRCA2 EGFR SYNE2 UTRN | 3.50e-05 | 340 | 171 | 12 | int:TERF2 |
| Interaction | DUSP16 interactions | CEP85 VPS13C CEP164 CCDC88A BRCA2 CDK5RAP2 AKAP11 CEP295 KNL1 PCNT | 3.61e-05 | 237 | 171 | 10 | int:DUSP16 |
| Interaction | PHF21A interactions | CENPF GIT2 RB1CC1 BIRC6 RAD50 CCDC88A DST BRCA2 UTRN CCDC93 KNL1 PCNT | 3.82e-05 | 343 | 171 | 12 | int:PHF21A |
| Interaction | OFD1 interactions | CEP85 SDCCAG8 CEP290 RB1CC1 CEP164 RAD50 CEP170 CEP135 SASS6 CDK5RAP2 CEP295 PCNT | 4.27e-05 | 347 | 171 | 12 | int:OFD1 |
| Interaction | MIB1 interactions | MIS18BP1 ATAD5 ITSN1 CEP290 EPB41L5 RB1CC1 TMCC3 AP2A2 CEP135 SASS6 PCNT | 4.56e-05 | 295 | 171 | 11 | int:MIB1 |
| Interaction | MDC1 interactions | RNF169 MYO1D ATAD5 SMC1A IFI16 YY1 RAD50 SINHCAF BRD2 BRCA1 BRCA2 RECQL5 KNL1 | 5.51e-05 | 414 | 171 | 13 | int:MDC1 |
| Interaction | NEURL4 interactions | 6.01e-05 | 116 | 171 | 7 | int:NEURL4 | |
| Interaction | SASS6 interactions | 6.52e-05 | 159 | 171 | 8 | int:SASS6 | |
| Interaction | ERCC2 interactions | 6.55e-05 | 81 | 171 | 6 | int:ERCC2 | |
| Interaction | CFAP184 interactions | 7.43e-05 | 162 | 171 | 8 | int:CFAP184 | |
| Interaction | FRAT2 interactions | 7.54e-05 | 27 | 171 | 4 | int:FRAT2 | |
| Interaction | RAD50 interactions | RNF169 BRIP1 SMC1A SPTA1 CCDC150 RFC1 ZUP1 RAD50 BRCA1 BRCA2 EGFR RECQL5 | 8.10e-05 | 371 | 171 | 12 | int:RAD50 |
| Interaction | NDEL1 interactions | 8.10e-05 | 164 | 171 | 8 | int:NDEL1 | |
| Interaction | RCOR1 interactions | CENPF GIT2 RB1CC1 BIRC6 RAD50 CCDC88A DST BRCA2 CEP135 CAMSAP1 UHRF2 UTRN CCDC93 KNL1 | 8.54e-05 | 494 | 171 | 14 | int:RCOR1 |
| Interaction | CCDC138 interactions | 8.71e-05 | 123 | 171 | 7 | int:CCDC138 | |
| Interaction | BRK1 interactions | 9.16e-05 | 124 | 171 | 7 | int:BRK1 | |
| Interaction | SLFN11 interactions | MYO1D CENPF MYH7B SMC1A RB1CC1 RFC1 DHX8 RAD50 BRCA1 EGFR RBM19 ZNF91 | 9.19e-05 | 376 | 171 | 12 | int:SLFN11 |
| Interaction | TNIK interactions | CACNA1E CENPF RAPGEF4 SHANK3 GATAD2B CEP170 DST AP2A2 EGFR ZC3H4 SYNE2 NCK2 | 1.04e-04 | 381 | 171 | 12 | int:TNIK |
| Interaction | SLX4 interactions | RNF169 BRIP1 MIS18BP1 SMC1A YY1 GATAD2B RAD50 BRD2 BRCA1 AP2A2 BRCA2 SERPINB3 RECQL5 PDS5A ILKAP | 1.13e-04 | 572 | 171 | 15 | int:SLX4 |
| Interaction | CCDC14 interactions | 1.17e-04 | 129 | 171 | 7 | int:CCDC14 | |
| Interaction | NUP62 interactions | ITSN1 SDCCAG8 CCDC150 IFI16 CCDC88A EGFR SYNE2 SASS6 CCDC93 PCNT | 1.17e-04 | 273 | 171 | 10 | int:NUP62 |
| Interaction | LZTS2 interactions | TRAF5 MIS18BP1 CEP85 CEP290 BIRC6 SHANK3 CEP164 CCDC88A BRCA2 EGFR CEP135 SASS6 CEP295 NCK2 | 1.24e-04 | 512 | 171 | 14 | int:LZTS2 |
| Interaction | PURG interactions | 1.25e-04 | 223 | 171 | 9 | int:PURG | |
| Interaction | MKI67 interactions | CENPF SMC1A PFDN1 IFI16 YY1 SINHCAF DST FAM111A BRCA1 BAIAP2L1 BRCA2 PDS5A SCAF11 UHRF2 UTRN ILKAP | 1.33e-04 | 648 | 171 | 16 | int:MKI67 |
| Interaction | EZH1 interactions | 1.33e-04 | 92 | 171 | 6 | int:EZH1 | |
| Interaction | FNTA interactions | 1.50e-04 | 94 | 171 | 6 | int:FNTA | |
| Interaction | NINL interactions | MIS18BP1 CEP85 RIBC2 SDCCAG8 CEP290 CEP170 BRCA1 BRCA2 SASS6 COBL CEP295 CAMSAP1 PCNT | 1.51e-04 | 458 | 171 | 13 | int:NINL |
| Interaction | MAPRE3 interactions | 1.58e-04 | 230 | 171 | 9 | int:MAPRE3 | |
| Interaction | CPAP interactions | 1.67e-04 | 182 | 171 | 8 | int:CPAP | |
| Interaction | TRAF3IP1 interactions | 1.69e-04 | 96 | 171 | 6 | int:TRAF3IP1 | |
| Interaction | NBN interactions | 1.73e-04 | 183 | 171 | 8 | int:NBN | |
| Interaction | MRE11 interactions | RNF169 BRIP1 SMC1A SPTA1 RFC1 RAD50 PCF11 BRCA1 RECQL5 UHRF2 | 1.76e-04 | 287 | 171 | 10 | int:MRE11 |
| Interaction | CIAO1 interactions | TRAF5 BRIP1 CENPF VPS13C KTN1 EPB41L5 CCDC7 SINHCAF EGFR KNL1 | 1.87e-04 | 289 | 171 | 10 | int:CIAO1 |
| Interaction | POLE interactions | 1.87e-04 | 139 | 171 | 7 | int:POLE | |
| Interaction | APEX1 interactions | RNF169 BRIP1 CENPF YBX1 ATAD5 ITSN1 KTN1 CEP290 EPB41L5 ARMC10 BUD13 RFC1 YY1 ZNF568 BRD2 SEMA6D BRCA1 AP2A2 BRCA2 EGFR UGP2 PDS5A SCAF11 ARHGEF3 | 1.91e-04 | 1271 | 171 | 24 | int:APEX1 |
| Interaction | TERF1 interactions | CEP85 CENPF YY1 RAD50 DST BRCA1 BAIAP2L1 BRCA2 SYNE2 ARHGEF3 UTRN | 1.92e-04 | 347 | 171 | 11 | int:TERF1 |
| Interaction | AKAP17A interactions | 2.00e-04 | 99 | 171 | 6 | int:AKAP17A | |
| Interaction | PPIA interactions | BRIP1 CEP85 CENPF ITSN1 EPB41L5 RFC1 YY1 SHANK3 DHX8 RAD50 CEP170 DST BAIAP2L1 ZC3H4 SERPINB3 SASS6 CAMSAP1 KNL1 ILKAP | 2.01e-04 | 888 | 171 | 19 | int:PPIA |
| Interaction | HERC1 interactions | 2.32e-04 | 144 | 171 | 7 | int:HERC1 | |
| Interaction | GOLGA6L2 interactions | 2.38e-04 | 36 | 171 | 4 | int:GOLGA6L2 | |
| Interaction | DBN1 interactions | MYO1D EPB41L5 MYO1B RB1CC1 SHANK3 CHUK DST BRD2 AP2A2 ZC3H4 COBL ILKAP | 2.40e-04 | 417 | 171 | 12 | int:DBN1 |
| Interaction | H3C1 interactions | RNF169 BRIP1 ATAD5 SMC1A CEP290 RFC1 YY1 ESCO1 GATAD2B CHUK RAD50 BRD2 EGFR ZC3H4 RECQL5 PDS5A CAMSAP1 UHRF2 DNAH8 | 2.41e-04 | 901 | 171 | 19 | int:H3C1 |
| Interaction | PRKACB interactions | 2.49e-04 | 193 | 171 | 8 | int:PRKACB | |
| Interaction | C1QTNF9 interactions | 2.66e-04 | 37 | 171 | 4 | int:C1QTNF9 | |
| Interaction | TERF2IP interactions | BRIP1 ATAD5 RFC1 GATAD2B DHX8 RAD50 PCF11 BRCA1 BRCA2 ZC3H4 RECQL5 PDS5A SCAF11 KNL1 | 2.70e-04 | 552 | 171 | 14 | int:TERF2IP |
| Interaction | CCDC18 interactions | 2.81e-04 | 68 | 171 | 5 | int:CCDC18 | |
| Interaction | BPTF interactions | 2.86e-04 | 197 | 171 | 8 | int:BPTF | |
| Interaction | CEP350 interactions | 2.86e-04 | 149 | 171 | 7 | int:CEP350 | |
| Interaction | TRIM28 interactions | CENPF ZNF569 YBX1 ZNF273 IFI16 BIRC6 SHANK3 ZUP1 DHX8 RAD50 ZNF675 ZNF430 ZNF514 BRCA1 BRCA2 ZNF544 EGFR ZNF684 ZNF41 RECQL5 PDS5A ZNF85 ZNF91 UHRF2 DNAH8 ILKAP | 2.95e-04 | 1474 | 171 | 26 | int:TRIM28 |
| Interaction | RALBP1 interactions | 2.96e-04 | 198 | 171 | 8 | int:RALBP1 | |
| Interaction | H2BC21 interactions | CYLC1 CACNA1E RNF169 CENPF ATAD5 RFC1 IFI16 ESCO1 GATAD2B RAD50 SINHCAF BRD2 BRCA1 ZC3H4 AKAP11 SCAF11 | 2.98e-04 | 696 | 171 | 16 | int:H2BC21 |
| Interaction | ZBTB7B interactions | TBX3 YBX1 KTN1 CCDC175 MYO1B RFC1 YY1 CCDC39 GATAD2B BGN NCK2 | 3.03e-04 | 366 | 171 | 11 | int:ZBTB7B |
| Interaction | SYNGAP1 interactions | KTN1 BIRC6 SHANK3 CEP170 CCDC88A SRGAP1 SYNE2 CAMSAP1 NCK2 PCNT | 3.03e-04 | 307 | 171 | 10 | int:SYNGAP1 |
| Interaction | PIBF1 interactions | 3.16e-04 | 200 | 171 | 8 | int:PIBF1 | |
| Interaction | CEP131 interactions | 3.16e-04 | 200 | 171 | 8 | int:CEP131 | |
| Interaction | VPS33A interactions | 3.20e-04 | 253 | 171 | 9 | int:VPS33A | |
| Interaction | SNAP91 interactions | 3.22e-04 | 70 | 171 | 5 | int:SNAP91 | |
| Interaction | CA8 interactions | 3.60e-04 | 40 | 171 | 4 | int:CA8 | |
| Interaction | NABP2 interactions | 3.67e-04 | 72 | 171 | 5 | int:NABP2 | |
| Interaction | NOP56 interactions | YBX1 ATAD5 BUD13 RFC1 IFI16 YY1 RAD50 FAM111A BRD2 BRCA1 EGFR RBM19 RECQL5 CEP295 | 3.72e-04 | 570 | 171 | 14 | int:NOP56 |
| Interaction | PML interactions | TBX3 RNF169 MYO1D SPTA1 RDX DTX3L ZHX2 IFI16 GATAD2B ITPR2 RAD50 CEP170 BRCA1 BAIAP2L1 EGFR SYNE2 PDS5A KNL1 ILKAP | 3.72e-04 | 933 | 171 | 19 | int:PML |
| Interaction | PRELID2 interactions | 3.74e-04 | 17 | 171 | 3 | int:PRELID2 | |
| Interaction | CALM2 interactions | 3.85e-04 | 206 | 171 | 8 | int:CALM2 | |
| Interaction | SUZ12 interactions | YBX1 CEP290 EPB41L5 CCDC141 YY1 BIRC6 GATAD2B JARID2 BRD2 BRCA1 CDK5RAP2 PDS5A SCAF11 UHRF2 PCNT | 4.02e-04 | 644 | 171 | 15 | int:SUZ12 |
| Interaction | ODF2 interactions | 4.08e-04 | 158 | 171 | 7 | int:ODF2 | |
| Interaction | DNM1 interactions | 4.08e-04 | 158 | 171 | 7 | int:DNM1 | |
| Interaction | MLF1 interactions | 4.08e-04 | 113 | 171 | 6 | int:MLF1 | |
| Interaction | H2BC8 interactions | RNF169 MIS18BP1 ATAD5 BUD13 RFC1 GATAD2B DHX8 BRD2 BRCA1 RECQL5 PDS5A AKAP11 SCAF11 ILKAP | 4.13e-04 | 576 | 171 | 14 | int:H2BC8 |
| Interaction | SYNE3 interactions | CEP85 VPS13C CEP164 TMCC3 DST BRCA2 SYNE2 CDK5RAP2 CEP295 TRIM13 CAMSAP1 PCNT | 4.23e-04 | 444 | 171 | 12 | int:SYNE3 |
| Interaction | TFPT interactions | 4.40e-04 | 160 | 171 | 7 | int:TFPT | |
| Interaction | GUSBP5 interactions | 4.43e-04 | 75 | 171 | 5 | int:GUSBP5 | |
| Interaction | LPXN interactions | 4.48e-04 | 115 | 171 | 6 | int:LPXN | |
| Interaction | KCNA3 interactions | MYO1D MYH7B SMC1A KTN1 EPB41L5 RDX MYO1B RAD50 CEP170 CCDC88A DST BAIAP2L1 EGFR COBL CDK5RAP2 PDS5A CAMSAP1 NCK2 | 4.49e-04 | 871 | 171 | 18 | int:KCNA3 |
| Interaction | HAUS6 interactions | 4.57e-04 | 161 | 171 | 7 | int:HAUS6 | |
| Interaction | NCL interactions | YBX1 SMC1A RDX RFC1 IFI16 YY1 RAD50 CEP170 SINHCAF BRCA1 BRCA2 EGFR ASXL3 RECQL5 UHRF2 CCDC65 SYT13 | 4.62e-04 | 798 | 171 | 17 | int:NCL |
| Interaction | GJA1 interactions | MYO1D ITSN1 KTN1 EPB41L5 ITPR2 PIK3R4 CCDC88A DST EGFR SYNE2 TRIM13 UTRN VPS13B NCK2 | 4.66e-04 | 583 | 171 | 14 | int:GJA1 |
| Interaction | MED4 interactions | ITSN1 CEP290 GIT2 CEP170 DST EGFR RECQL5 CEP135 SASS6 CAMSAP1 UTRN PCNT | 4.77e-04 | 450 | 171 | 12 | int:MED4 |
| Cytoband | 19p12 | 2.94e-05 | 90 | 180 | 5 | 19p12 | |
| Cytoband | 7q35 | 6.67e-05 | 55 | 180 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 1.25e-04 | 122 | 180 | 5 | chr19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 1.36e-04 | 66 | 180 | 4 | chr7q35 | |
| Cytoband | 12p11 | 5.40e-04 | 9 | 180 | 2 | 12p11 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF569 ZNF391 ZNF273 ZNF407 ZHX2 YY1 ZNF568 ZUP1 ZNF675 ZNF430 ZNF514 ZNF594 ZNF544 ZNF684 ZNF41 ZBTB40 ZNF770 ZNF85 ZNF91 ZNF730 ZNF286A | 8.37e-09 | 718 | 119 | 21 | 28 |
| GeneFamily | CTAGE family | 3.23e-08 | 15 | 119 | 5 | 907 | |
| GeneFamily | Myosin heavy chains | 2.30e-06 | 15 | 119 | 4 | 1098 | |
| GeneFamily | Ankyrin repeat domain containing|BRCA1 B complex | 2.56e-04 | 4 | 119 | 2 | 1335 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.92e-04 | 20 | 119 | 3 | 548 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.24e-04 | 5 | 119 | 2 | 1336 | |
| GeneFamily | Myosins, class I | 1.17e-03 | 8 | 119 | 2 | 1097 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.26e-03 | 181 | 119 | 6 | 694 | |
| GeneFamily | Ring finger proteins | 2.30e-03 | 275 | 119 | 7 | 58 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MIS18BP1 VPS13C KTN1 CEP290 AGGF1 RDX ZNF407 RB1CC1 RFC1 IFI16 ITPR2 RAD50 CEP170 ZNF430 CCDC88A FAM111A BRCA1 SYNE2 CDK5RAP2 AKAP11 SCAF11 ZNF85 EEA1 KNL1 | 8.90e-12 | 656 | 171 | 24 | M18979 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | CENPF SMC1A ITSN1 RFC1 CCDC88A DST BRCA2 SASS6 CDK5RAP2 ARHGEF3 NCK2 PCNT | 8.06e-09 | 199 | 171 | 12 | M5893 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPF ITSN1 RDX MYO1B RB1CC1 ZHX2 YY1 PIK3R4 PCF11 CEP170 JARID2 DST BRCA1 BRCA2 EGFR ZC3H4 SYNE2 CEP135 PDS5A AKAP11 VPS13B CCDC93 PCNT | 9.64e-09 | 856 | 171 | 23 | M4500 |
| Coexpression | GSE2706_2H_VS_8H_LPS_STIM_DC_DN | MYH7B RDX DTX3L TMCC3 ZUP1 CFB FSD1L SINHCAF CEP135 CFAP70 NCK2 | 6.48e-08 | 194 | 171 | 11 | M4733 |
| Coexpression | FISCHER_DREAM_TARGETS | BRIP1 MIS18BP1 CEP85 CENPF ZNF273 ATAD5 SMC1A CCDC150 RDX RFC1 BIRC6 PCF11 FAM111A BRCA1 BRCA2 ZNF684 CEP135 SASS6 CDK5RAP2 CEP295 ZNF85 KNL1 PCNT | 9.23e-08 | 969 | 171 | 23 | M149 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | MIS18BP1 CEP85 CENPF ATAD5 RDX BUD13 ACYP1 CCDC88A FAM111A BRCA1 BRCA2 SYNE2 SASS6 CDK5RAP2 CEP295 ZNF85 KLRC2 KNL1 PCNT | 1.54e-07 | 694 | 171 | 19 | M45767 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | CENPF ZHX2 PIK3R4 PCF11 CEP170 JARID2 DST ZC3H4 SCAF11 TRIM13 VPS13B CCDC93 | 7.07e-07 | 300 | 171 | 12 | M8702 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.41e-06 | 212 | 171 | 10 | M39221 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRAF5 MIS18BP1 YBX1 VPS13C KTN1 APBA2 AGGF1 GIT2 RB1CC1 IFI16 BIRC6 GATAD2B ITPR2 PCF11 JARID2 CCDC88A TRANK1 FAM111A UGP2 PDS5A PNRC1 AKAP11 SCAF11 ARHGEF3 UTRN KLRC2 VPS13B | 1.42e-06 | 1492 | 171 | 27 | M40023 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL | MIS18BP1 CEP85 CENPF CCDC178 CCDC88A BRCA2 SASS6 CEP295 CCDC171 KNL1 | 2.05e-06 | 221 | 171 | 10 | M45789 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | BRIP1 MIS18BP1 CEP85 CENPF ATAD5 BUD13 ACYP1 CCDC88A FAM111A BRCA1 BRCA2 SYNE2 CEP135 SASS6 CDK5RAP2 CEP295 ZNF85 UHRF2 KNL1 PCNT | 3.55e-06 | 939 | 171 | 20 | M45768 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 5.49e-06 | 194 | 171 | 9 | M7467 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CENPF ITSN1 MYO1B ZHX2 CEP170 JARID2 DST BRCA1 EGFR ZC3H4 CEP135 PDS5A CCDC93 | 1.27e-05 | 466 | 171 | 13 | M13522 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | RAPGEF4 ERI2 ACYP1 JARID2 ARHGAP6 DST SYNE2 COBL ZNF91 CAMSAP1 PCNT | 1.55e-05 | 340 | 171 | 11 | M2012 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | MYO1D VPS13C RDX GIT2 ACYP1 IFI16 TF RAD50 GSTT2 TRANK1 AP2A2 RBM19 SYNE2 PNRC1 | 2.28e-05 | 567 | 171 | 14 | M16909 |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 5.31e-05 | 200 | 171 | 8 | M8614 | |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP | 5.49e-05 | 148 | 171 | 7 | M1892 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 6.50e-05 | 152 | 171 | 7 | M2964 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 6.53e-05 | 206 | 171 | 8 | M39254 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | BRIP1 CENPF ATAD5 RDX ACYP1 CCDC88A FAM111A BRCA1 BRCA2 SYNE2 KNL1 PCNT | 7.58e-05 | 478 | 171 | 12 | M45785 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | BRIP1 MIS18BP1 CENPF ZNF273 ATAD5 VPS13C CCDC7 DST BRCA1 BRCA2 SASS6 AKAP11 CEP295 ZNF85 FHDC1 EEA1 KNL1 | 7.95e-05 | 892 | 171 | 17 | M18120 |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 1.62e-04 | 176 | 171 | 7 | M8248 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CENPF ATAD5 SMC1A KTN1 CEP290 EPB41L5 ARMC10 GIT2 RB1CC1 CEP164 ZUP1 RAD50 CCDC88A BRCA1 BRCA2 SRGAP1 SYNE2 CEP135 PDS5A CEP295 EEA1 ZNF91 CAMSAP1 CCDC171 KNL1 | 1.22e-08 | 831 | 170 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | CENPF ATAD5 SMC1A KTN1 CEP290 BRCA1 BRCA2 SYNE2 CEP135 PDS5A CEP295 KNL1 | 4.98e-08 | 192 | 170 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CENPF ATAD5 SMC1A CEP290 RAD50 CCDC88A BRCA1 BRCA2 SRGAP1 SYNE2 CEP135 PDS5A CEP295 KNL1 | 2.24e-07 | 311 | 170 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CENPF ATAD5 VPS13C KTN1 CEP290 EPB41L5 ZHX2 BIRC6 ESCO1 PCF11 FAM111A BRCA1 BRCA2 CEP135 PDS5A SCAF11 KDM7A PCNT | 2.91e-07 | 532 | 170 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MIS18BP1 CENPF ATAD5 SMC1A KTN1 CEP290 RDX RFC1 ERI2 ZUP1 DHX8 RAD50 JARID2 FSD1L SINHCAF CCDC88A BRCA1 BRCA2 SYNE2 CEP135 SASS6 PDS5A ZNF770 SCAF11 CEP295 CAMSAP1 UHRF2 KNL1 | 8.05e-07 | 1257 | 170 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | MIS18BP1 CEP85 CENPF ZNF569 ATAD5 SMC1A KTN1 CEP290 EPB41L5 RFC1 ERI2 ZUP1 DHX8 RAD50 FBXO16 JARID2 FSD1L SINHCAF CCDC88A BRCA1 BRCA2 SULF1 SYNE2 CEP135 SASS6 CEP295 CAMSAP1 KNL1 | 4.27e-06 | 1370 | 170 | 28 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | MIS18BP1 CENPF ATAD5 SMC1A KTN1 CEP290 RDX RFC1 ERI2 ZUP1 DHX8 RAD50 JARID2 FSD1L SINHCAF CCDC88A BRCA1 BRCA2 SYNE2 CEP135 SASS6 PDS5A ZNF770 SCAF11 CEP295 CAMSAP1 UHRF2 KNL1 | 1.38e-05 | 1459 | 170 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | MIS18BP1 CENPF ATAD5 SMC1A CEP290 MYO1B CCDC122 RB1CC1 RFC1 ERI2 FREM1 ZUP1 RAD50 JARID2 SINHCAF CCDC88A BRCA2 ZNF41 SYNE2 CEP135 ZNF770 CEP295 ZNF91 CAMSAP1 KNL1 | 2.20e-05 | 1252 | 170 | 25 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | CENPF ATAD5 SMC1A KTN1 CEP290 EPB41L5 BRCA1 RBM19 SYNE2 PDS5A SCAF11 | 2.96e-05 | 298 | 170 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CENPF ATAD5 SMC1A KTN1 CEP290 EPB41L5 ARMC10 RAD50 FSD1L SINHCAF CCDC88A BRCA1 BRCA2 SRGAP1 SYNE2 CEP135 PDS5A CEP295 CCDC171 KNL1 PCNT | 4.45e-05 | 989 | 170 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CENPF ATAD5 SMC1A KTN1 CEP290 ZNF407 DHX8 RAD50 CEP170 BRCA2 ZC3H4 SYNE2 CDK5RAP2 PNRC1 CEP295 KNL1 | 4.80e-05 | 629 | 170 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CENPF ATAD5 SMC1A KTN1 CEP290 EPB41L5 SINHCAF BRCA1 BRCA2 SYNE2 CEP135 PDS5A CEP295 KNL1 | 5.03e-05 | 498 | 170 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | MIS18BP1 CENPF ATAD5 MYH7B SMC1A CEP290 RDX CCDC122 ZUP1 ITPR2 RAD50 JARID2 SINHCAF CCDC88A BRCA1 BRCA2 ZNF41 ASXL3 CEP135 ZNF770 SCAF11 CEP295 UHRF2 KNL1 | 5.44e-05 | 1241 | 170 | 24 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | BRIP1 MIS18BP1 CEP85 CENPF CCDC150 CHUK SYCP2 TRANK1 BRCA1 BRCA2 ZNF41 DNAH8 | 6.66e-05 | 385 | 170 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.09e-04 | 232 | 170 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | MIS18BP1 CENPF SMC1A CEP290 CCDC88A BRCA1 BRCA2 SRGAP1 SCAF11 ZNF91 | 1.24e-04 | 291 | 170 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MIS18BP1 CENPF SMC1A CEP290 GIT2 RB1CC1 CEP164 ZUP1 CCDC88A BRCA1 BRCA2 SRGAP1 SYNE2 SCAF11 EEA1 ZNF91 CAMSAP1 | 1.82e-04 | 780 | 170 | 17 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ATAD5 SMC1A ZNF407 DHX8 ITPR2 RAD50 PIK3R4 CEP170 CDK5RAP2 PNRC1 ZNF770 UHRF2 UTRN KNL1 | 1.86e-04 | 564 | 170 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.45e-04 | 204 | 170 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | BRIP1 MIS18BP1 CENPF ATAD5 ITSN1 TF BRCA1 BRCA2 HP SYNE2 KNL1 | 3.04e-04 | 388 | 170 | 11 | GSM538352_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | BRIP1 MIS18BP1 CEP85 CENPF CCDC150 ESCO1 CHUK RAD50 SYCP2 TRANK1 BRCA1 BRCA2 ZNF41 AKAP11 CEP295 CCDC171 DNAH8 | 3.25e-04 | 820 | 170 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | MIS18BP1 CENPF ATAD5 SMC1A CEP290 EPB41L5 ERI2 RAD50 FSD1L SINHCAF CCDC88A BRCA1 BRCA2 SYNE2 CEP135 SASS6 CEP295 ZNF91 CAMSAP1 KNL1 | 3.29e-04 | 1060 | 170 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | MIS18BP1 CENPF ZNF569 SMC1A CEP290 ARMC10 CCDC88A BRCA1 BRCA2 ASXL3 SRGAP1 SYNE2 COBL AKAP11 SCAF11 CFAP70 ZNF91 CCDC171 UTRN | 3.56e-04 | 985 | 170 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | BRIP1 MIS18BP1 CEP85 CENPF CCDC150 RAD50 SYCP2 BRCA2 ZNF41 TRIM13 CCDC171 | 3.62e-04 | 396 | 170 | 11 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | BRIP1 MIS18BP1 CENPF ATAD5 ERI2 BRCA1 BRCA2 SASS6 DNAH8 NCK2 KNL1 | 3.77e-04 | 398 | 170 | 11 | GSM399397_500 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | BRIP1 MIS18BP1 CENPF ATAD5 ITSN1 CEP290 TF BRCA1 BRCA2 HP KNL1 | 3.85e-04 | 399 | 170 | 11 | GSM538345_500 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | MYO1D ITSN1 CCDC122 SHANK3 BGN ARHGAP6 CCDC88A DST BRCA2 HP SYNE2 | 4.74e-04 | 409 | 170 | 11 | GSM476663_500 |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | MIS18BP1 CEP85 RIBC2 CENPF SYCP2 BRCA1 BRCA2 CEP135 CEP295 CCDC171 UTRN KNL1 PCNT | 9.47e-13 | 194 | 175 | 13 | dff3fb10372053951d41e0ccd41aac3ece6009bd |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | VPS13C ITSN1 KTN1 CEP290 RDX RB1CC1 YY1 RAD50 SYNE2 ZNF770 SCAF11 EEA1 | 2.51e-11 | 199 | 175 | 12 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | BRIP1 MIS18BP1 CENPF ATAD5 CCDC150 ERI2 CCDC88A BRCA1 BRCA2 SASS6 CDK5RAP2 KNL1 | 2.66e-11 | 200 | 175 | 12 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | RIBC2 CENPF ZNF273 RAPGEF4 TTC6 ZBBX BRCA2 CEP295 CFAP70 CCDC171 DNAH11 | 3.44e-11 | 157 | 175 | 11 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | YBX1 VPS13C MYO1B RB1CC1 YY1 ESCO1 ITPR2 SYNE2 PDS5A AKAP11 SCAF11 | 2.83e-10 | 191 | 175 | 11 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | YBX1 VPS13C MYO1B RB1CC1 YY1 ESCO1 ITPR2 SYNE2 PDS5A AKAP11 SCAF11 | 2.83e-10 | 191 | 175 | 11 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | CENPF VPS13C CEP290 RB1CC1 RAD50 CEP170 CCDC88A EGFR SYNE2 SCAF11 UTRN | 4.15e-10 | 198 | 175 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | BRIP1 CENPF ATAD5 CCDC150 SEMA6D BRCA1 BRCA2 FHDC1 ZNF730 KNL1 | 4.45e-09 | 190 | 175 | 10 | e83fa8b711aa79a1767818474f1c193b674b1c31 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | YBX1 VPS13C MYO1B RB1CC1 YY1 ESCO1 SYNE2 PDS5A AKAP11 SCAF11 | 4.68e-09 | 191 | 175 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | MIS18BP1 VPS13C KTN1 CEP290 RB1CC1 YY1 CCDC39 RAD50 SYNE2 EEA1 | 6.93e-09 | 199 | 175 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | VPS13C KTN1 CEP290 RB1CC1 IFI16 RAD50 CCDC88A SYNE2 PNRC1 EEA1 | 6.93e-09 | 199 | 175 | 10 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.93e-09 | 199 | 175 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | BRIP1 MIS18BP1 CENPF ATAD5 CCDC150 BRCA1 BRCA2 SYNE2 CDK5RAP2 KNL1 | 6.93e-09 | 199 | 175 | 10 | 98575fcce726589e93fbb4df1aab03e57cb56076 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | BRIP1 MIS18BP1 CENPF ATAD5 CCDC150 BRCA1 BRCA2 SYNE2 SASS6 KNL1 | 6.93e-09 | 199 | 175 | 10 | be2276c9a1994579ba1d2998b49bf549c1324d44 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MIS18BP1 CENPF ATAD5 CCDC150 ERI2 CCDC88A BRCA1 BRCA2 CDK5RAP2 KNL1 | 7.27e-09 | 200 | 175 | 10 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | BRIP1 MIS18BP1 CENPF ATAD5 BRCA1 BRCA2 SYNE2 CEP135 CDK5RAP2 KNL1 | 7.27e-09 | 200 | 175 | 10 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | BRIP1 MIS18BP1 CENPF ATAD5 BRCA1 BRCA2 SYNE2 CEP135 CDK5RAP2 KNL1 | 7.27e-09 | 200 | 175 | 10 | 0675f580ccef705875854247bbfd4ee2bcf126a1 |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | BRIP1 MIS18BP1 CENPF ATAD5 SMC1A FAM111A BRCA1 BRCA2 SYNE2 KNL1 | 7.27e-09 | 200 | 175 | 10 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | BRIP1 MIS18BP1 CENPF ATAD5 SMC1A FAM111A BRCA1 BRCA2 SYNE2 KNL1 | 7.27e-09 | 200 | 175 | 10 | dc1c1506823eaa105f1532c6b5d4efa14e788314 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.18e-08 | 180 | 175 | 9 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | BRIP1 MIS18BP1 CENPF ATAD5 CCDC150 BRCA1 BRCA2 CDK5RAP2 KNL1 | 5.29e-08 | 185 | 175 | 9 | 30e041d6f6e310d64809e9d6d93cd30052972f3b |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-08 | 187 | 175 | 9 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-08 | 189 | 175 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.65e-08 | 190 | 175 | 9 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.65e-08 | 190 | 175 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.61e-08 | 193 | 175 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.61e-08 | 193 | 175 | 9 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.61e-08 | 193 | 175 | 9 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.95e-08 | 194 | 175 | 9 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.31e-08 | 195 | 175 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.31e-08 | 195 | 175 | 9 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.68e-08 | 196 | 175 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.07e-08 | 197 | 175 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.07e-08 | 197 | 175 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 9.88e-08 | 199 | 175 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.03e-07 | 200 | 175 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-07 | 167 | 175 | 8 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-07 | 169 | 175 | 8 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.66e-07 | 169 | 175 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.19e-07 | 177 | 175 | 8 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-07 | 184 | 175 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 7.26e-07 | 185 | 175 | 8 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.56e-07 | 186 | 175 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-07 | 187 | 175 | 8 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-07 | 187 | 175 | 8 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-07 | 187 | 175 | 8 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-07 | 187 | 175 | 8 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 8.87e-07 | 190 | 175 | 8 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 9.23e-07 | 191 | 175 | 8 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.98e-07 | 193 | 175 | 8 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-06 | 194 | 175 | 8 | e5b81a8e52259a54a911c1c2ac932c98c988318d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.04e-06 | 194 | 175 | 8 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.08e-06 | 195 | 175 | 8 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.08e-06 | 195 | 175 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.08e-06 | 195 | 175 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-06 | 196 | 175 | 8 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.12e-06 | 196 | 175 | 8 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-06 | 196 | 175 | 8 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-06 | 196 | 175 | 8 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.16e-06 | 197 | 175 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.26e-06 | 199 | 175 | 8 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-06 | 199 | 175 | 8 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.30e-06 | 200 | 175 | 8 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.30e-06 | 200 | 175 | 8 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.30e-06 | 200 | 175 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.30e-06 | 200 | 175 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 200 | 175 | 8 | 5e1b38e2aa8901bfb2623249f7b6302e97d56ace | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 3.82e-06 | 163 | 175 | 7 | 47300dec94dc66e965bf71fafff0a9fd24fae968 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-06 | 163 | 175 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.98e-06 | 164 | 175 | 7 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-06 | 167 | 175 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-06 | 168 | 175 | 7 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.04e-06 | 170 | 175 | 7 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 174 | 175 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.32e-06 | 176 | 175 | 7 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 178 | 175 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.81e-06 | 178 | 175 | 7 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-06 | 181 | 175 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 7.59e-06 | 181 | 175 | 7 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 7.87e-06 | 182 | 175 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.16e-06 | 183 | 175 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.45e-06 | 184 | 175 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.45e-06 | 184 | 175 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.76e-06 | 185 | 175 | 7 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.07e-06 | 186 | 175 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-06 | 186 | 175 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.07e-06 | 186 | 175 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.07e-06 | 186 | 175 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.39e-06 | 187 | 175 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 189 | 175 | 7 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 189 | 175 | 7 | 16dfc37d8d390ed7f927bc844c47c9c5a89a0928 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 189 | 175 | 7 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 189 | 175 | 7 | 3ade3fa9369e85304b20d7233b581f18ad5ecc89 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-05 | 189 | 175 | 7 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 189 | 175 | 7 | 8a38baee58a27c2fa3f4bd131ab9f15723ed9295 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 1.04e-05 | 190 | 175 | 7 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 190 | 175 | 7 | 31de1727822e9818652946dfb962daee77ffad68 | |
| Drug | Clorgyline | VPS13C KTN1 CEP290 RAPGEF4 RB1CC1 ESCO1 RAD50 DST CEP135 AKAP11 SCAF11 UTRN | 5.24e-09 | 168 | 170 | 12 | ctd:D003010 |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A | ATAD5 SMC1A CAMK1 YY1 PCF11 BRCA2 CEP135 ZBTB40 COBL CAMSAP1 | 2.51e-06 | 198 | 170 | 10 | 6238_UP |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 8.40e-07 | 14 | 162 | 4 | C0677776 | |
| Disease | Autosomal recessive primary microcephaly | 1.14e-06 | 15 | 162 | 4 | cv:C3711387 | |
| Disease | BREAST CANCER | 4.87e-06 | 21 | 162 | 4 | 114480 | |
| Disease | Autosomal Recessive Primary Microcephaly | 5.93e-06 | 22 | 162 | 4 | C3711387 | |
| Disease | Malignant tumor of breast | 1.39e-05 | 27 | 162 | 4 | cv:C0006142 | |
| Disease | Breast neoplasm | 1.39e-05 | 27 | 162 | 4 | cv:C1458155 | |
| Disease | Familial cancer of breast | 1.39e-05 | 27 | 162 | 4 | cv:C0346153 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MYH1 TBX3 BRIP1 RIBC2 CENPF ZNF569 YBX1 KTN1 DTX3L RB1CC1 BGN PIK3R4 BRCA1 BRCA2 EGFR HP SYNE2 VPS13B | 2.71e-05 | 1074 | 162 | 18 | C0006142 |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 3.00e-05 | 2 | 162 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 3.00e-05 | 2 | 162 | 2 | C4749652 | |
| Disease | Charcot-Marie-Tooth disease (biomarker_via_orthology) | 3.00e-05 | 2 | 162 | 2 | DOID:10595 (biomarker_via_orthology) | |
| Disease | Ciliopathies | 3.34e-05 | 110 | 162 | 6 | C4277690 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 3.45e-05 | 12 | 162 | 3 | C0403553 | |
| Disease | distal myopathy (implicated_via_orthology) | 3.45e-05 | 12 | 162 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.45e-05 | 12 | 162 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.46e-05 | 13 | 162 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | Primary ciliary dyskinesia | 4.50e-05 | 36 | 162 | 4 | cv:C0008780 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 7.04e-05 | 15 | 162 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.57e-05 | 41 | 162 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.57e-05 | 41 | 162 | 4 | C0858252 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 8.09e-05 | 80 | 162 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | dihomo-linoleate 20:2n6 measurement | 8.95e-05 | 3 | 162 | 2 | EFO_0021064 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 1.48e-04 | 19 | 162 | 3 | DOID:9744 (biomarker_via_orthology) | |
| Disease | Adenocarcinoma of prostate | 1.73e-04 | 20 | 162 | 3 | C0007112 | |
| Disease | Hereditary breast ovarian cancer syndrome | 1.78e-04 | 4 | 162 | 2 | cv:C0677776 | |
| Disease | Primary microcephaly | 2.32e-04 | 22 | 162 | 3 | C0431350 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 2.96e-04 | 5 | 162 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | diacylglycerol 44:6 measurement | 2.96e-04 | 5 | 162 | 2 | EFO_0020070 | |
| Disease | interleukin-10 receptor subunit beta measurement | 2.96e-04 | 5 | 162 | 2 | EFO_0020489 | |
| Disease | Fanconi Anemia | 3.42e-04 | 25 | 162 | 3 | C0015625 | |
| Disease | breast cancer (implicated_via_orthology) | 3.42e-04 | 25 | 162 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | age at diagnosis, substance-related disorder | 4.43e-04 | 6 | 162 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 4.43e-04 | 6 | 162 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | Adult only | 4.43e-04 | 6 | 162 | 2 | C3842001 | |
| Disease | Miller Dieker syndrome | 5.34e-04 | 29 | 162 | 3 | C0265219 | |
| Disease | Prostate cancer, familial | 5.73e-04 | 69 | 162 | 4 | C2931456 | |
| Disease | Breast Cancer, Familial | 5.91e-04 | 30 | 162 | 3 | C0346153 | |
| Disease | heparin cofactor 2 measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0008150 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 6.18e-04 | 7 | 162 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Renal dysplasia and retinal aplasia | 6.18e-04 | 7 | 162 | 2 | cv:C0403553 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 6.39e-04 | 71 | 162 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 6.78e-04 | 525 | 162 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 6.78e-04 | 525 | 162 | 10 | C1257931 | |
| Disease | Mammary Neoplasms | 6.98e-04 | 527 | 162 | 10 | C1458155 | |
| Disease | Abnormality of radial ray | 7.85e-04 | 33 | 162 | 3 | C4228778 | |
| Disease | Breast Carcinoma | 8.17e-04 | 538 | 162 | 10 | C0678222 | |
| Disease | ovarian neoplasm | 8.86e-04 | 134 | 162 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 9.78e-04 | 137 | 162 | 5 | C1140680 | |
| Disease | Pancreatic carcinoma, familial | 1.05e-03 | 9 | 162 | 2 | C2931038 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.10e-03 | 37 | 162 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | red blood cell density measurement | SPTA1 ITSN1 LEKR1 EPB41L5 RFC1 TF DST ZC3H4 ZBTB40 ARHGEF3 UHRF2 KLRC2 VPS13B | 1.19e-03 | 880 | 162 | 13 | EFO_0007978 |
| Disease | obsolete_red blood cell distribution width | BRIP1 MYO1D SPTA1 ITSN1 LEKR1 BUD13 ZNF407 RFC1 BIRC6 TF CEP170 ZC3H4 SYNE2 ZBTB40 PDS5A KNL1 ILKAP | 1.23e-03 | 1347 | 162 | 17 | EFO_0005192 |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 1.28e-03 | 39 | 162 | 3 | DOID:9744 (implicated_via_orthology) | |
| Disease | hyperglycemia (is_implicated_in) | 1.31e-03 | 10 | 162 | 2 | DOID:4195 (is_implicated_in) | |
| Disease | Fanconi anemia (is_implicated_in) | 1.31e-03 | 10 | 162 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | beta thalassemia (is_marker_for) | 1.59e-03 | 11 | 162 | 2 | DOID:12241 (is_marker_for) | |
| Disease | smoking status measurement, forced expiratory volume | 1.59e-03 | 11 | 162 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | colorectal cancer (is_marker_for) | 1.79e-03 | 157 | 162 | 5 | DOID:9256 (is_marker_for) | |
| Disease | non-high density lipoprotein cholesterol measurement | SPTA1 PFDN1 DTX3L CFB BRCA2 HP ZC3H4 SYNE2 PDS5A PMFBP1 DNAH11 | 2.02e-03 | 713 | 162 | 11 | EFO_0005689 |
| Disease | Primary Ciliary Dyskinesia | 2.21e-03 | 47 | 162 | 3 | C4551720 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 2.25e-03 | 13 | 162 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | 3-formylindole measurement | 2.25e-03 | 13 | 162 | 2 | EFO_0801025 | |
| Disease | Benign tumor of pancreas | 2.25e-03 | 13 | 162 | 2 | C0347284 | |
| Disease | Bardet-Biedl Syndrome | 2.25e-03 | 13 | 162 | 2 | C0752166 | |
| Disease | urate measurement, bone density | 2.31e-03 | 619 | 162 | 10 | EFO_0003923, EFO_0004531 | |
| Disease | myopathy (implicated_via_orthology) | 2.34e-03 | 48 | 162 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Fanconi anemia | 2.61e-03 | 14 | 162 | 2 | cv:C0015625 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.61e-03 | 14 | 162 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | bilirubin measurement | 3.17e-03 | 442 | 162 | 8 | EFO_0004570 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 3.86e-03 | 17 | 162 | 2 | EFO_0008270 | |
| Disease | Limb Deformities, Congenital | 3.86e-03 | 17 | 162 | 2 | C0206762 | |
| Disease | Polydactyly | 4.01e-03 | 117 | 162 | 4 | C0152427 | |
| Disease | prostate cancer (is_implicated_in) | 4.01e-03 | 117 | 162 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | serum hepcidin measurement | 4.33e-03 | 18 | 162 | 2 | EFO_0004504 | |
| Disease | Bone marrow hypocellularity | 4.33e-03 | 18 | 162 | 2 | C1855710 | |
| Disease | Bardet-Biedl syndrome | 4.33e-03 | 18 | 162 | 2 | cv:C0752166 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 4.33e-03 | 18 | 162 | 2 | OBA_2045065 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 4.52e-03 | 121 | 162 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | Chronic myeloproliferative disorder | 4.82e-03 | 19 | 162 | 2 | C1292778 | |
| Disease | Pancreatic carcinoma | 4.82e-03 | 19 | 162 | 2 | C0235974 | |
| Disease | response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement | 5.33e-03 | 20 | 162 | 2 | EFO_0803359, EFO_0803362 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AKNLHSNQSKELLGK | 311 | Q7L8C5 | |
| AFHTLEKSLKQKSNL | 216 | Q9HBT8 | |
| LQLHTDKGSFLKEKN | 461 | Q96QE3 | |
| KHEKFTIQLQLSQKS | 111 | Q5SW79 | |
| QGKNEHLAFNTKSKA | 356 | A8K979 | |
| QAKSHFGDKKQLDSK | 331 | Q9BRD0 | |
| SPKSHIDKANFNNEK | 71 | P07311 | |
| KLKEQIFEASKAHLN | 481 | O42043 | |
| KLKEQIFEASKAHLN | 591 | Q9UKH3 | |
| SNQVAAKALLDHKKQ | 216 | Q9NR81 | |
| QQKAKLEAKLHQTTA | 1646 | Q9NR09 | |
| LNKQKITFEDSKVHA | 241 | Q8IX94 | |
| KENAHNKQKLTETEL | 481 | Q8IX94 | |
| LNKQKITFEDSKVHA | 241 | Q86UF2 | |
| KENAHNKQKLTETEL | 481 | Q86UF2 | |
| LNKQKITFEDSKVHA | 241 | P0CG41 | |
| KENAHNKQKLTETEL | 481 | P0CG41 | |
| LNKQKITFEDSKVHA | 241 | A4FU28 | |
| LNKQKITFEDSKVHA | 241 | A4D2H0 | |
| KENAHNKQKLTETEL | 481 | A4D2H0 | |
| EAFNQKHALQKAKEV | 721 | Q15878 | |
| KKQKSFQDNQLSTHN | 696 | Q96M83 | |
| SINAQLKGHQKTDKN | 1136 | Q96M83 | |
| LNEFKQSKLITHEKF | 1021 | Q6TFL3 | |
| QFLKDKLAKEEHNSA | 41 | Q8IXS2 | |
| KLAKEEHNSALNLNK | 46 | Q8IXS2 | |
| ETALKDFHKKQISQL | 1766 | Q96DT5 | |
| VTFKHGNLDQKNKSK | 526 | Q9UKA4 | |
| SSFEDVHLLQNKNKK | 666 | Q8N302 | |
| AKKKLQSLSNHLFEE | 266 | Q14161 | |
| SNSENCKELQLEKHK | 561 | Q99767 | |
| KESLAFAQQHKAKDP | 976 | Q5T5Y3 | |
| VSSFQQHTKKALKQA | 146 | Q9C0F0 | |
| KINHSNQSIKEKALN | 146 | Q8N2F6 | |
| SKKVQHSNAKNAVLF | 296 | O94973 | |
| YKSLLSESNKKLHNQ | 461 | Q96SN8 | |
| HLANNVKEKLSEKQA | 766 | Q9UFE4 | |
| SEEEAQKAQKHFNKS | 51 | Q9Y4C8 | |
| AHKNLNKQSFDLAKV | 216 | Q29RF7 | |
| KLNKELASSEQNKNH | 596 | Q92878 | |
| KDLKHNDGNFTEKQK | 516 | P25092 | |
| KQAKQGNHTEAALLK | 76 | Q14571 | |
| QHKAFAAQEDLEKTK | 446 | P35241 | |
| ALASKKDNEQHVFKV | 441 | P00751 | |
| LQNKDNEFALVKHEK | 906 | Q8TDY2 | |
| QKKDTILLNFSEKLH | 346 | Q9C0D6 | |
| EDILSSKLNGKFNKH | 546 | Q6ZMT4 | |
| KKHLFEDSQNKLGAE | 421 | Q17RR3 | |
| VKYQNSSLKLNDHKK | 46 | Q6P0N0 | |
| SSLKLNDHKKNQFLK | 51 | Q6P0N0 | |
| AKNLFLNHSENATAK | 201 | P00738 | |
| NEFQKVKKQLSHLQD | 101 | Q6ZMV7 | |
| ASGKNKHFKVQLVDN | 326 | O43639 | |
| FKIKHSNEKKSQSQN | 586 | Q86W26 | |
| KTQLAQHKEFQKSLG | 6741 | Q03001 | |
| TFAAKHNNKVKALDV | 431 | Q9BXM9 | |
| SASQQLKAKLEFFHK | 471 | O15111 | |
| EDKANQLQHFEKQKT | 236 | Q5BJE1 | |
| SFKQNEFLHLKDTNK | 836 | Q5CZC0 | |
| TDHKNLKSLLNNSKL | 1266 | Q3V6T2 | |
| LTKEKKALQEAHQQA | 1041 | A7E2Y1 | |
| QSKEAIHSQLLEKQK | 71 | O60925 | |
| TENIKNSHLKKSAFL | 256 | Q12796 | |
| LHFLNVKKVKTDTEN | 76 | Q9HCI6 | |
| LVNNKISKIHEKAFS | 121 | P21810 | |
| KDSKNSKKTNTEFLH | 201 | P35663 | |
| KLKTIDNVNFSKLHT | 111 | Q96JB1 | |
| HEKFSQKDLNSKTIL | 1691 | Q5H8C1 | |
| KFVAKENEVQSLHSK | 521 | Q86UP2 | |
| LKNDKTIVFSENHKN | 1096 | Q8NG31 | |
| LTKEKKALQEAHQQT | 996 | P12882 | |
| TSNQKKALKAEHTNR | 446 | Q8WXI9 | |
| SNLSLAKEQHLQKKY | 346 | Q9H4K1 | |
| VKGQHKSKEFLQINS | 36 | P0CG30 | |
| EEKESLSLQLQKKNH | 1086 | O95613 | |
| VALKHEQTAKDNLQK | 2706 | O95613 | |
| LAEFSKKHQKVLNVS | 881 | Q9BX63 | |
| IHQSVSEQIKKNFAK | 286 | Q14012 | |
| NKLSHTKDLKNQESE | 376 | O94913 | |
| NLLHKQKSSDKEFSV | 561 | O43182 | |
| NFAKKENNSPEHLKD | 106 | P38398 | |
| LENKLKVQAQKFSHV | 641 | Q66GS9 | |
| SKKNIQATLHQKDLD | 331 | Q15075 | |
| TEKLKNQSESHKQAQ | 581 | Q15075 | |
| KDSLSINATNIKHFK | 346 | P00533 | |
| SLNKQIAQKTKHLEE | 321 | Q567U6 | |
| KVTKEDSLLSHKNAN | 576 | Q9HCM4 | |
| THKKLNESLDENFKK | 81 | Q9UHR4 | |
| FHESQQNQKSNLKTK | 71 | Q96BT1 | |
| KSQQLKDLIHFHQKQ | 761 | Q6ZP82 | |
| KTQIKLHLSAKANNA | 896 | Q8NCX0 | |
| TASNKEIKLSEHNIK | 1011 | P51587 | |
| QIKSLHSENVKLKFD | 96 | Q5T0U0 | |
| KNKDHFETLKNLENG | 631 | P0C221 | |
| KENNLLKSHSEQKAR | 486 | P49454 | |
| AEKKHQALLLDTNKQ | 2706 | P49454 | |
| NSAFKQAIQASHKKD | 296 | P13671 | |
| KQANKFKQELNHQFT | 316 | Q8TDB6 | |
| KLKEQIFEASKAHLN | 481 | P61566 | |
| KLKEQIFEASKAHLN | 481 | P61567 | |
| QEKLHALEKQFSKDT | 2026 | O15078 | |
| AQTHILKKNFAKAEE | 936 | Q5T0N1 | |
| TFSQSKSKQKEDNHI | 156 | Q96PZ2 | |
| KSKQKEDNHIFGRQD | 161 | Q96PZ2 | |
| AKKDNHLNFNKNDVI | 926 | Q15811 | |
| VKGQHKSKEFLQINS | 36 | P0CG29 | |
| DHQKQSQQLKDSELK | 491 | Q6P2H3 | |
| SNLHTDNLNAKVKDK | 636 | O75128 | |
| KHTDEEFLKQASSQK | 196 | Q9H0C8 | |
| KLKEQIFEASKAHLN | 591 | P61565 | |
| HVKVLNTSLKEKFNG | 241 | Q16666 | |
| LSKFNSVQHNKLDSQ | 396 | Q5FWF5 | |
| PDFSRQSHDKKNKLQ | 256 | Q8IX29 | |
| LNKQRKLNKSESAEH | 1626 | Q9C0D2 | |
| QQIQKHEETLKDFFK | 1741 | Q9C0D2 | |
| DKKNENSFEKQVSCH | 111 | Q99590 | |
| LTNKHSQELTNEKEK | 206 | Q6UVJ0 | |
| ALADQKKAKFHQTEG | 1026 | Q14562 | |
| SLKEFKNSQKRQHAE | 36 | Q92833 | |
| SLQAQLDKALQKEKH | 706 | Q8TBY8 | |
| VSHKAQEENFKKELQ | 326 | Q6ZV65 | |
| NFEKVSQHIKSAKLL | 1736 | P46939 | |
| QKKHKVLLQQFNTGD | 641 | Q8WZA2 | |
| TKDHQQYKKDQNLLS | 81 | Q7Z6B7 | |
| KLKLTNNISDKHGFT | 206 | O15119 | |
| DDKHTLLAKNAQQKK | 261 | Q8TEL6 | |
| IKQVFEKKNQKSAHS | 111 | Q9ULS5 | |
| KSAHSIAQLQKKLEQ | 121 | Q9ULS5 | |
| NTKKSVLQDHFSKLL | 1826 | Q8WXH0 | |
| AFKHKIKDSDNAELN | 191 | P26717 | |
| FSSVQANLSKAEKHK | 251 | P35251 | |
| KEQLKHKEFLLAANT | 261 | Q86SQ7 | |
| NKNHLQKQAEKNFTD | 91 | Q5TEA6 | |
| DAKNKIQTHLAKTLQ | 356 | Q9BXF9 | |
| KQLENALTVHLSKKF | 821 | Q6ZUB0 | |
| LTKEKKALQEAHQQT | 996 | Q9Y623 | |
| RNEQVKQAFHDSLKK | 291 | A6NDL8 | |
| VLKTKQQLKTLNHFD | 586 | Q8NCN4 | |
| TLIEFNKKFQEKTHQ | 596 | Q6P1J6 | |
| NKKFQEKTHQLIESG | 601 | Q6P1J6 | |
| HSQSSLEKQELKKVN | 1281 | Q6P1J6 | |
| KDNTAQQIKKVLHFD | 46 | P29508 | |
| NIHKAQLSKNEERFK | 381 | O00463 | |
| QQHQSSKKGKLSEQL | 336 | P25440 | |
| ELKKHSQENIKFENS | 721 | Q8TBZ0 | |
| QKHFSSLEAEAQKKQ | 1026 | Q9UPV0 | |
| ASKKQQLLATAAHKD | 746 | O94762 | |
| KSNKAKANIVDQSHL | 796 | Q99570 | |
| NQISKLQKEFKRHNS | 106 | Q9NP50 | |
| KFDTKSHNDDALLKN | 171 | P01242 | |
| GNIKHKSKENTNKLD | 176 | Q96PU4 | |
| KQLENALTVHLSKKF | 821 | P0C874 | |
| NTDEDTKKILQKYNH | 166 | Q16851 | |
| GKAFSQKSNLIVHQK | 361 | Q5T5D7 | |
| KAFNQFSNLTKHKII | 241 | Q14593 | |
| SQKDHYKSQAELLQK | 271 | P0CB48 | |
| FEKLQHTLDQKKNEI | 186 | O60858 | |
| KSFSQKQNLIEHEKI | 341 | Q3ZCX4 | |
| LNQAQEHFGKDKSKE | 286 | P02787 | |
| EATKQAQKDFLKALH | 261 | Q86TZ1 | |
| KEDVFVHQTAIKKNN | 81 | P67809 | |
| LIDDKQFAKLHTKAN | 101 | Q9BYB0 | |
| HQSQDSRIKKLDKFQ | 1401 | Q9BX26 | |
| NKKFAQSTNLKSHIL | 391 | P25490 | |
| EKHIQDVLQFSKLKA | 101 | Q96K75 | |
| VHLKSLTEKNQTDKA | 136 | A8MX80 | |
| KLEAAKKSLQNAQKH | 311 | Q14683 | |
| ITAKLDEKKQQSSLH | 81 | A0A0B4J273 | |
| VKEQGLFHKKDSANQ | 3691 | Q709C8 | |
| LKDKLISAQHNQSKA | 1991 | P02549 | |
| LQQFSHIKKDVTLSK | 956 | Q9UPT8 | |
| EDKVNHLTKNNSKLS | 206 | Q9H6N6 | |
| KAFNQSSNLTEHKKI | 291 | Q6ZMV8 | |
| KNLKTFVKHQQLHNE | 91 | Q6IQ21 | |
| CDKAFNQSANLTKHK | 541 | Q8TD23 | |
| VHLKSLTEKNQTDKA | 106 | A8MV72 | |
| GKAFNQFSNLTKHKI | 491 | Q9H8G1 | |
| KAFNQSSILTNHKKI | 1141 | Q05481 | |
| KTKEQIAHLKASFLQ | 446 | Q9Y6X8 | |
| VHLKSLTEKNQTDKA | 136 | Q8N9G6 | |
| KNSAQNLTKDSTLKH | 101 | Q96AP4 | |
| GKAFTDQSNLIKHQK | 571 | P51814 | |
| EKSFSQKSNLIDHEK | 276 | Q5MCW4 | |
| VKELKQNSAFINHEK | 191 | Q6NX49 | |
| DQINLFLKKIKNAHS | 2061 | Q7Z7G8 | |
| QNFKQKSGLTEHQKI | 106 | Q96JF6 | |
| GKAFNQSSNLIKHKK | 236 | Q03923 | |
| CEKAFNQSSKLTEHK | 431 | Q03923 | |
| SKHLENAKKNNIGLS | 756 | Q9C0G0 | |
| NKNFKAIEKINSHLE | 291 | O15050 | |
| FSNSNAHKAEKKLQN | 841 | Q8NFY4 | |
| KKEESSKNIQQSNHL | 421 | Q8IWU6 | |
| HLKSLTEKNQTDKAQ | 136 | A6NL46 | |
| DNKKQNLHAAVKDSL | 276 | A8MT70 | |
| KVSNKFHLEANNKED | 681 | Q9NUA8 | |
| SRKNSKDNSDLIKHQ | 86 | Q9UJN7 | |
| IKPNDKKAAHIFNEA | 596 | O43795 | |
| NGKDQLVVFHTKDNK | 911 | O94832 | |
| DLSQQVHKAAAEKFK | 1471 | O15069 | |
| LKAQQQAKAVLKHFN | 701 | Q8N9H8 |